Impurity Supplier in India / Vender of API Impurities India
Rxn Chemical is world largest impurity manufacturer and exporter like USA, China, Europe, Middle East, Canada. we are top impurity supplier in India. Kindly contact us for pharama intermediates and API
Cetirizine Impurity 6 | NA | C11H14Cl2O2S | 281.2 |
Cetirizine Impurity 7 | NA | C23H23ClN2O2S | 426.97 |
Cetirizine Impurity 8 DiHCl | 200707-85-3 | C21H26ClN3O2. 2 HCl | 387.91 2 36.46 |
Cetirizine Impurity (4-Chlorobenzophenone) | C13H9ClO | 216.67 | |
Cetirizine Lactose Ester | C33H45ClN2O13 | 713.19 | |
Deschloro Cetirizine Dihydrochloride | 83881-54-3 | C21H26N2O3 . HCl | 354.45 36.46 |
Cetirizine Methyl Ester | C22H27ClN2O3 | 402.93 | |
(S)-Cetirizine | 130018-76-7 | C21H25ClN2O3.2 HCl | 388.90 2 36.46 |
4-Chloro Benzhydrol (Meclozine EP Impurity B) | 119-56-2 | C13H11ClO | 218.69 |
Cetirizine Impurity D | 346451-15-8 | C30H28Cl2N2. | 487.48 |
Cetirizine Related Compound | 108983-83-1 | C19H24N2O 2HCl | 296.42 2x36.46 |
Cetirizine Propanediol Ester Impurity | N/A | C24H31ClN2O4 | 446.98 |
Cetirizine Glycerol Ester Impurity | N/A | C24H31ClN2O5 | 462.98 |
Cetirizine Related Compound D | N/A | C22H27ClN2O3 | 402.93 |
Cetirizine diHCl | 83881-52-1 | C21H25ClN2O3. 2 HCl | 388.90 2 36.46 |
Cetirizine 3-chloro Impurity | 1232460-29-5 | C21H25ClN2O3 | 388.9 |
(R)-Cetirizine N-Oxide DiHCl | 442863-80-1 (free base) | C21H25ClN2O4. 2 HCl | 404.90 2 36.46 |
Cetirizine N-Oxide DiHCl | 1076199-80-8 (free base) | C21H25ClN2O4. 2 HCl | 404.90 2 36.46 |
(S)-Cetirizine-d4 | 130018-76-7(non-d) | C21H25ClN2O3.2 HCl | 388.90 2 36.46 |
Cetirizine Impurity D DiHCl | 856841-95-7 | C30H28Cl2N2. 2 HCl | 487.48 2 36.46 |
(R)-Cetirizine Polyethylene Glycol Ester | C21H25ClN2O3[C2H4O]n | 388.90[44.05]n | |
Cetirizine N,N-Dioxide DiHCl | C21H25ClN2O5. 2 HCl | 420.90 2 36.46 | |
Cetirizine Sorbitol Ester Impurity HCl | 13848888-64-5 (free base) | C27H37ClN2O8. HCl | 553.06 36.46 |
(R)-Cetirizine diHCl (Levocetirizine diHCl) | 130018-87-0 | C21H25ClN2O3. 2 HCl | 388.90 2 36.46 |
(R)-Cetirizine-d4 | 130018-77-8(non-d) | C21H25ClN2O3.2 HCl | 388.90 2 36.46 |
Cetirizine-d8 | 774596-22-4 | C21H17ClN2O3D8.2 HCl | 396.95 2 36.46 |
Cetirizine Impurity A | 303-26-4 | C17H19ClN2 | 286.81 |
Cetirizine Impurity B | NA | C19H21ClN2O2 | 344.84 |
(s)-(-)-Carbidopa-d3 | 1276732-89-8 | C10H11N2O4D3 | 229.25 |
Carbidopa | C10H14N2O4 | 226.23 | |
Carbidopa-d6 | N/A | C10H8N2O4D6 | 232.27 |
2-Bromo Carbidopa | 1246817-47-9 | C10H13BrN2O4 | 305.13 |
3-Bromo Carbidopa | 1246819-09-9 | C10H13BrN2O4 | 305.13 |
6-Hydroxy Chlorzoxazone | 1750-45-4 | C7H4ClNO3 | 185.57 |
6-Hydroxy Chlorzoxazone-d2 | 1750-45-4(non-d) | C7H2ClNO3D2 | 187.58 |
Chlorzoxazone-d3 | 95-25-0(non-d) | C7HClNO2D3 | 172.59 |
6-Hydroxy Chlorzoxazone-15N-d2 | 1750-45-4 (non-d) | C7H2ClNO3D2 | 188.57 |
Chlorzoxazone | C7H4ClNO2 | 169.57 | |
Chlorpyriphos-d10 | 39475-55-3 (non-d) | C9HCl3NO3PSD10 | 360.65 |
Chlorpyriphos impurity (O,O-bis-(3,5,6-trichloropyridin-2-yl) hydrogen thiophosphate) | C10H3Cl6N2O3PS | 474.9 | |
Clofibric acid-d4 | 882-09-7 (non-d) | C10H7ClO3D4 | 218.67 |
Clofibrate-d4 | 637-07-0 (non-d) | C10H7ClO3D4 | 246.73 |
Clofibric acid-acyl-beta-D-Glucuronide | 72072-47-0 | C16H19ClO9 | 390.78 |
Clonidine-d4 HCl | 67151-02-4(non-d) | C9H5Cl2N3D4.HCl | 34.12 36.46 |
4-Hydroxy Clonidine | 57101-48-1 | C9H9Cl2N3O | 246.1 |
Clotrimazole-d5 | 23593-75-1 (non-d) | C22H12ClN2D5 | 349.87 |
1-(2-Chlorophenyl-diphenylmethyl)-1H-pyrazole | 289905-88-0 | C22H17ClN2 | 344.85 |
2-Chlorophenyl-phenyl-dichloromethane | 3509-85-1 | C13H9N3 | 271.58 |
2-Chlorophenyl-diphenylmethane | 56153-60-7 | C19H15Cl | 278.78 |
Clotrimazole | 23593-75-1 | C22H17ClN2 | 344.85 |
Clotrimazole Impurity A | 66774-02-5 | C19H15ClO | 294.78 |
Clotrimazole Impurity B | 23593-71-7 | C22H17ClN2 | 344.85 |
Clotrimazole Impurity C | 42074-68-0 | C19H14Cl2 | 313.23 |
Clotrimazole Impurity E | 08-03-5162 | C13H9ClO | 216.67 |
Clotrimazole Impurity F | 15469-97-3 | C22H18N2 | 310.4 |
2-Chlorophenyl-trichloromethane | 2136-89-2 | C7H4Cl4 | 229.92 |
Cortisone-d2 | 53-06-5 (non-d) | C21H26O5D2 | 362.47 |
20-beta-Dihydrocortisol-d4 | N/A | C21H28O5D4 | 368.51 |
Hydrocortisone Impurity D | 53-35-0 | C21H30O6 | 378.47 |
Hydrocortisone Impurity H | N/A | C21H30O6 | 378.47 |
Hydrocortisone Impurity I | 103795-84-2 | C21H30O6 | 378.47 |
Hydrocortisone Impurity M | 566-35-8 | C21H30O5 | 362.47 |
Hydrocortisone Impurity N | N/A | C42H58O10 | 722.92 |
Hydrocortisone Impurity O | N/A | C21H30O6 | 378.47 |
6-beta-Hydroxycortisol Glucuronide | N/A | C27H38O12 | 554.6 |
6-beta-Hydroxycortisol Sulfate | 53587-06-7 | C21H30O9S | 458.53 |
21-Deoxy Cortisone | 1882-82-2 | C21H28O4 | 344.45 |
Cortisol-d2 | 50-23-7(non-d) | C21H28O5D2 | 364.48 |
17alpha,20beta-Dihydroxy-4-pregnen-3-one | C21H32O3 | 332.49 | |
17alpha,20beta-Dihydroxy-4-pregnen-3-one-d4 | C21H28O3D4 | 336.51 | |
6-Dehydrocortisol Acetate | 21940-45-4 | C23H30O6 | 402.49 |
21-Chloro Hydrocortisone | C21H27ClO3 | 362.9 | |
21-Deoxy Hydrocortisone | C21H28O3 | 328.46 | |
Hydrocortisone Impurity G | 14760-49-7 | C21H28O5 | 360.45 |
Hydrocortisone Impurity L (Oxenol) | C21H30O4 | 346.47 | |
Hydrocortisone Impurity K | 640-87-9 | C23H32O5 | 388.51 |
Cortisol-d4 | 73565-87-4 | C21H26O5D4 | 366.49 |
11-Deoxycortisol-d2 | NA | C21H28O4D2 | 348.48 |
Tetrahydro-11-deoxy Cortisol | C21H34O4 | 350.5 | |
Tetrahydro-11-deoxy Cortisol-d5 | C21H29O4D5 | 355.53 | |
Cortisol-d5 | N/A | C21H25O5D5 | 367.5 |
20-beta-Dihydrocortisol | 116-58-5 | C21H32O5 | 364.49 |
20-beta-Dihydrocortisol-d5 | N/A | C21H27O5D5 | 369.52 |
Cyproterone Acetate Impurity F (Cyproterone) | 2098-66-0 | C22H27ClO3 | 374.91 |
Cyproterone Impurity I | 13698-49-2 | C23H27ClO4 | 402.92 |
Cyproterone Impurity E | 17184-05-3 | C24H30O5 | 398.5 |
Cyproterone Impurity B | C25H32O5 | 412.53 | |
Cyproterone Impurity G | C24H31ClO5 | 434.96 | |
Cyproterone Impurity C | C24H30Cl2O4 | 453.41 | |
Cyproterone Impurity A | C24H30O4 | 382.5 | |
Cyproterone Impurity J | 15423-97-9 | C24H30O5 | 398.5 |
Cyproterone-d5 | 2098-66-0 (non-d) | C24H26ClO3D5 | 407.97 |
Cyproterone acetate | 427-51-0 | C24H29ClO4 | 416.95 |
Cyproterone acetate-13C2-d3 | 427-51-0 (non-d) | C26H30ClO4D3 | 450.02 |
Cyproterone acetate-d5 | 427-51-0 (non-d) | C26H28ClO4D5 | 450.02 |
15-Hydroxy cyproterone | C24H31ClO4 | 418.97 | |
15-Hydroxy cyproterone acetate | C26H33ClO5 | 461 | |
Cyproterone Acetate-d3 | C24H26ClO4D3 | 419.97 | |
15-beta-Hydroxy Cyproterone | 65423-26-9 | C24H29ClO5 | 432.95 |
Creatinine-d3 | 143827-20-7(non-d) | C4H4N3OD3 | 116.14 |
Cyanazine-d5 | C9H8ClN6D5 | 245.73 | |
Cyclobenzaprine-d3 HCl | 352431-15-3 | C20H18ND3.HCl | 278.42 36.46 |
Cyclobenzaprine Related Compound A | 18029-54-4 | C20H23NO | 293.41 |
3-Hydroxy Cyclobenzaprine | 30235-48-4 | C20H21NO | 291.4 |
3,5-Dihydroxy-N-Methylprotriptyline | 30235-47-3 | C20H23NO2 | 309.4 |
Cyclobenzaprine | 303-53-7 | C20H21N | 275.4 |
Cyclobenzaprine-13C-d3 | 303-53-7(non-d) | C20H18ND3 | 279.4 |
Cyclobenzaprine N-Glucuronide (mixture of isomers) | C26H29NO6 | 451.52 | |
Cyclobenzaprine N-oxide | 6682-26-4 | C20H21NO | 291.4 |
N-Desmethyl Cyclobenzaprine-d3 HCl | C19H16ND3. HCl | 264.39 36.46 | |
N-Desmethyl Cyclobenzaprine HCl | C19H19N.HCl | 261.37 36.46 | |
Cyclobenzaprine-d6 HCl | C20H15ND6.HCl | 281.43 36.46 | |
Cyclobenzaprine-N-Glucuronide-d3 (mixture of isomers) Bromide | C26H27NO6D3.Br | 455.55 79.90 | |
Clauvanic Acid Impurity A | C8H12N2O2 | 168.2 | |
Clavulanic acid-d4 | C8H5NO5D4 | 203.19 | |
Clavulanic Acid Impurity G | C13H15NO6 | 281.27 | |
Clauvanic Acid Impurity B | C11H16N2O4 | 240.26 | |
Clauvanic Acid Impurity C | 86917-74-0 | C10H16N2O2 | 196.25 |
Clauvanic Acid Impurity D | C7H9NO3 | 155.15 | |
Clauvanic Acid Impurity E | C16H18N2O10 | 398.33 | |
Clauvanic Acid Impurity F | C13H14N2O5 | 278.27 | |
Clauvanic Acid Impurity G | C26H26N2O11 | 542.5 | |
Potassium Clavulanate | 61177-45-5 | C8H8NO5. K | 198.16 39.10 |
Clavulanic Acid Imidazole-d3 Derivative | C10H10N3O3D3 | 226.25 | |
Chlorguanide (Proguanil) | 500-92-5 | C11H16ClN5 | 253.74 |
Chlorguanide-d6 HCl | 500-92-5 (non-d) | C11H10ClN5D6.HCl | 259.77 36.46 |
Chlorguanide Impurity A (Proguanil Impurity A) | 44830-55-9 | C5H10N4 | 126.16 |
Cycloguanil | 516-21-2 | C11H14ClN5 | 251.72 |
Cycloguanil-d6 | 516-21-2 (non-d) | C11H8ClN5D6 | 257.76 |
Capecitabine-d11 | 154361-50-9 (non-d) | C15H11FN3O6D11 | 370.42 |
3̢۪-(5̢۪-Deoxy-Alfa-D-ribofuranoyl) Capecitabine | 1262133-68-5 | C20H30FN3O9 | 475.48 |
Capecitabine impurity E | 910129-15-6 | C15H22FN3O6 | 359.36 |
Capecitabine impurity F | 162204-30-0 | C15H22FN3O6 | 359.36 |
alpha-Capecitabine | C15H22FN3O6 | 359.36 | |
2̢۪, 3̢۪-Di-O-acetyl-5̢۪-Deoxy-5-Fluoro-D-Cytidine | 161599-46-8 | C13H16FN3O6 | 329.29 |
2̢۪, 3̢۪-Di-O-acetyl-5̢۪-Deoxy-5-Fluoro-N4-(Pentoxycarbonxyl)-Cytidine | 162204-20-8 | C19H26FN3O8 | 443.43 |
Capecitabine Related Compound C | 921769-65-5 | C16H20FN3O7 | 385.35 |
Capecitabine Related Compound (alpha-isomer) | C13H16FN3O6 | 329.29 | |
Capecitabine | 154361-50-9 | C15H11FN3O6D11 | 359.36 |
5'-DFCR (5'-Deoxy-5-fluorocytidine) | 66335-38-4 | C9H12FN3O4 | 245.21 |
5'-DFUR (5'-Deoxy-5-fluorouridine, Doxifluridine) | 05-09-3094 | C9H11FN2O5 | 246.2 |
5'-DFUR-13C5 (5'-Deoxy-5-fluorouridine, Doxifluridine-13C5) | 3094-09-5 (non-labeled) | C9H11FN2O5 | 251.22 |
Tetrahydrouridine | 18771-50-1 | C9H11FN2O5 | 246.2 |
3̢۪-(5̢۪-Deoxy-Beta-D-ribofuranoyl) Capecitabine | 1262133-64-1 | C20H30FN3O9 | 475.48 |
2̢۪-(5̢۪-Deoxy-Beta-D-ribofuranoyl) Capecitabine | 1262133-66-3 | C20H30FN3O9 | 475.48 |
Colchicine-13C-d3 | 64-86-8-9 (non-d) | C22H22NO6D3 | 403.45 |
Clarithromycin-13C-d3 | 81103-11-9 (non-d) | C38H66NO13D3 | 751.98 |
Clarithromycin Impurity C | 127253-06-9 | C38H70N2O13 | 762.99 |
14-Hydroxy clarithromycin-13C-d3 | C38H66NO14D3 | 767.98 | |
N-Desmethyl Clarithromycin | NULL | C37H67NO13 | 733.95 |
Clarithromycin | C38H69NO13 | 747.97 | |
Clarithromycin N-Oxide | C38H69NO14 | 763.97 | |
Clarithromycin Impurity F | C39H72NO13 | 763.01 | |
Clarithromycin Impurity G | C39H72N2O13 | 777.01 | |
Clarithromycin Impurity H | C30H55NO10 | 589.77 | |
Clarithromycin Impurity E | C39H71NO13 | 762 | |
Cinnarizine | 298-57-7 | C26H28N2 | 368.53 |
Cinnarizine-d8 | 298-57-7 (non-d) | C26H20N2D8 | 376.58 |
Cinnarizine Impurity A | C17H20N2 | 252.36 | |
Cinnarizine Impurity B | 750512-44-8 | C26H28N2 | 368.53 |
Cinnarizine Impurity C | C35H37N2Cl | 521.13 | |
Cinnarizine Impurity D | C35H36N2 | 484.69 | |
(Z)-Cinnarizine-d8 | 16699-20-0 (non-labelled) | C26H20D8N2 | 376.56 |
Cinnarizine Impurity E | 216581-01-0 | C30H30N2 | 418.59 |
Cinacalcet (R-Enantiomer) HCl | 364782-34-3 | C22H22F3N. HCl | 357.42 36.46 |
Cinacalcet Impurity 3 | C22H22F3N | 357.42 | |
Cinacalcet Impurity 4 HCl | C22H20F3N. HCl | C22H20F3N. HCl | |
Cinacalcet Impurity 5 | C22H24F3N | 359.44 | |
Cinacalcet Impurity 6 | C10H9F3 | 186.18 | |
Cinacalcet Impurity 7 | 21172-43-0 | C11H13F3O3S | 282.28 |
Cinacalcet Impurity 8 | C32H31F6N | 543.6 | |
Cinacalcet Impurity 9 HCl | 253337-60-9 (free base) | C22H25N. HCl | 303.45 36.46 |
Cinacalcet Impurity 10 | C22H22F3N | 357.42 | |
Cinacalcet Dihydro Impurity 1 HCl | 1020414-33-8 | C22H24F3N HCl | 359.44 36.46 |
Cinacalcet Dihydro Impurity 2 HCl | 802918-36-1 (free base) | C22H24F3N HCl | 359.44 36.46 |
Cinacalcet-d3 (R-Enantiomer) | 226256-56-0 (non-d) | C22H19F3ND3 | 360.44 |
Cinacalcet impurity 11 | C22H26F3N | 361.45 | |
Cinacalcet impurity 12 | C22H28F3N | 363.47 | |
Cinacalcet Defluoro Impurity | N/A | C22H23F2N | 339.43 |
Cinacalcet Impurity 13 | C22H22F3N | 357.42 | |
rac Cinacalcet-d3 (methyl-d3) Hydrochloride | 364782-34-3 (non-d) | C22H22F3N2 HCl | 396.9 |
rac Cinacalcet HCl | C22H22F3N . HCl | 357.42 36.46 | |
Tetrahydro Cinacalcet Impurity | C22H26F3N | 361.45 | |
Cinacalcet N-Oxide Impurity | 1229224-94-5 | C22H21F3NO | 372.41 |
(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]methyl]-1-naphthalenemethaneamine | C20H18F3N | 329.37 | |
(S)-Cinacalcet HCl (ent-Cinacalcet HCl) | 694495-47-1 | C22H22F3N . HCl | 357.42 36.46 |
Cystine-d4 | 56-89-3 (non-d) | C6H8N2O4S2D4 | 244.33 |
Taurochenodeoxycholic Acid | C26H45NO6S | 499.72 | |
Chenodeoxycholic-2,2,4,4-D4 Acid | C24H36O4D4 | 396.61 | |
Taurochenodeoxycholic-2,2,4,4-D4 Acid | C26H41NO6SD4 | 503.74 | |
Cimetidine-d3 | C10H13N6SD3 | 255.36 | |
Cimetidine | 51481-61-9 | C10H16N6S | 252.34 |
Cimetidine Sulphoxide Dihydrochloride | 54237-72-8 | C10H16N6OS 2HCl | 268.34 2x36.46 |
Cimetidine Impurity D | N/A | C9H17N5S | 227.33 |
Cyromazin-d4 | C6H6N6D4 | 170.21 | |
Cytidine-d2 | C9H11N3O5D2 | 245.23 | |
5-Aza-2'-deoxy cytidine-15N4 | C8H12N4O4 | 232.18 | |
Cytidine 5'-Monophosphomorpholidate 4-Morpholine-N,N'-dicyclohexylcarboxamidine Salt | 76742-18-2 | C18H32N2O . C13H20N4O8P | 292.47 391.30 |
Cytidine-5'-Monophosphate Disodium Salt | 08-06-6757 | C9H12N3O8P . 2 Na | 321.19 2 22.99 |
Cytidine | 65-46-3 | C9H13N3O5 | 243.22 |
Carebastine | 90729-42-3 | C32H37NO4 | 499.66 |
Carebastine-d5 | 1189661-02-6 | C32H32NO4D5 | 504.69 |
Cephalexin | 15686-71-2 | C16H17N3O4S | 347.4 |
Cephalexin Impurity E | 146794-70-9 | C13H18N2O4S | 298.36 |
Cephalexin Impurity F | N/A | C16H17N3O4S | 347.4 |
Cephalexin Impurity J | C16H17N3O5S | 363.39 | |
Cephalexin Impurity K | C24H24N4O5S.CH2O2 | 480.55 46.03 | |
Cephalexin Diketopiperazine | 59865-11-1 | C16H17N3O4S | 347.4 |
Cephalexin Impurity A (D-2-Phenylglycine) | 875-74-1 | C8H9NO2 | 151.17 |
Cephalexin Impurity B | 22252-43-3 | C8H10N2O3S | 214.24 |
Cephalexin Related Compound | 37050-97-8 | C16H16N3O4S Na | 346.39 22.99 |
Cephalexin-d5 | 15686-71-2 (non-d) | C16H12N3O4SD5 | 352.43 |
Cephalexin Sulfoxide | 52210-38-5 | C16H17N3O5S | 363.39 |
L-Cephalexin | 34632-04-7 | C16H17N3O4S | 347.4 |
Cephalexin Related Compound (N-Ethoxycarbonyl-7-ADCA) | 72820-16-7 | C11H14N2O5S | 286.31 |
Cephalexin Phenylglycin | C24H24N4O5S | 480.55 | |
Cephalexin Dimer | C32H32N6O7S2 | 676.78 | |
Cephalexin Impurity C | N/A | C24H24N4O5S | 480.55 |
Cephalexin Impurity D | 34876-35-2 | C5H6O2S | 130.17 |
Chlorpheniramine-d4 maleate | 113-92-8 (non-d) | C16H15ClN2D4.C4H4O4 | 278.82 116.07 |
Chlorpheniramine N-Oxide HCl | C16H19ClN2O.HCl | 290.80 36.46 | |
Chlorpheniramine-d6 Maleate | 1185054-60-7 (free base) | C16H13ClN2D6. C4H4O4 | 280.83 116.07 |
S-Chlorpheniramine Maleate | C16H19ClN2.C4H4O4 | 274.80 116.07 | |
R-Chlorpheniramine Maleate | 23095-76-3 | C16H19ClN2. C4H4O4 | 274.80 116.07 |
Chlorpheniramine Maleate | C16H19ClN2. C4H4O4 | 274.80 116.07 | |
Chlorpheniramine Impurity D Maleate | C17H18ClN3. C4H4O4 | 299.81 116.07 | |
Chlorphenamine Impurity A Dimaleate | C16H24ClN3. 2 C4H4O4 | 293.84 2 116.07 | |
1-(3-chlorophenyl)-piperazine (m-CPP) | C10H13ClN2 | 196.68 | |
1-(3-chlorophenyl)-piperazine-d8 (m-CPP-d8) | C10H5ClN2D8 | 204.73 | |
Clindamycin-13C-d3 | C18H30ClN2O5SD3 | 429 | |
Clindamycin impurity (deshydro) | C18H32N2O5S | 388.53 | |
Clindamycin impurity (4-chloro) | C18H32Cl2N2O4S | 443.44 | |
Clindamycin Sulfoxide-13C, d3 | C18H30ClN2O6SD3 | 445 | |
Clindamycin sulfoxide | C18H33ClN2O6S | 440.99 | |
Clindamycin 3-Phosphate | C18H34ClN2O8PS | 504.97 | |
Clindamycin 4-Phosphate | C18H34ClN2O8PS | 504.97 | |
Clindamycin impurity B | 18323-43-8 | C17H31ClN2O5S | 410.96 |
Clindamycin impurity C (7-Epi Clindamycin) hydrochloride | 16684-06-3 | C18H33ClN2O5S .HCl | 424.99 36.5 |
Clindamycin impurity (sulfone) | C18H33ClN2O7S | 456.99 | |
Clindamycin impurity (hydrolysis product A) | C9H17NO2 | 171.24 | |
Clindamycin impurity (hydrolysis product B) | C9H18ClNO4S | 271.77 | |
Cholecalciferol-d7 | 67-97-0 (non-d) | C27H37OD7 | 391.69 |
Precalciferol (Previtamin D3) | 1173-13-3 | C27H44O | 384.65 |
1-alfa-25-Dihydroxycholecalciferol Impurity 1 | N/A | C27H44O3 | 416.65 |
1-alfa-25-Dihydroxycholecalciferol Impurity 2 | N/A | C27H44O3 | 416.65 |
25-Hydroxycholecalciferol | C27H44O2 | 400.65 | |
25-hydroxycholecalciferol-d6 | C27H38O3D6 | 422.69 | |
Cholecalciferol glucuronide | C33H52O7 | 560.78 | |
Cholecalciferol sulfate | C27H44O4S | 464.71 | |
Cholecalciferol Impurity A (5,6-trans-Cholecalciferol, 5,6-trans-Vitamin D3) | 22350-41-0 | C27H44O | 384.64 |
Cholecalciferol Impurity D (iso-Tachysterol 3) | 22350-43-2 | C27H44O | 384.64 |
Cholecalciferol Impurity E (Tachysterol 3) | 17592-07-3 | C27H44O | 384.64 |
Cholecalciferol Impurity C (lumisterol 3) | 07-01-5226 | C27H44O | 384.64 |
Cefprozil | 92665-29-7 | C18H19N3O5S | 389.43 |
Cefprozil-d4 | 92665-29-7 (non-d) | C18H15N3O5SD4 | 393.46 |
Cholesterol-d7 | C27H39OD7 | 393.71 | |
20(R), 22(R)-Dihydroxy Cholesterol | 53448-11-6 | C27H46O3 | 418.67 |
Cholestane-3β,5α,6β-triol | 1253-84-5 | C27H48O3 | 420.68 |
Cholestane-3β,5α,6β-triol-d5 | C27H43O3D5 | 425.71 | |
7a,12a-Dihydroxycholest-4-en-3-one-d3 | N/A | C27H41O3D3 | 419.67 |
22-alpha-Hydroxy Cholesterol | 17954-98-2 | C27H46O2 | 402.67 |
(3-beta)-7-Dehydrocholesterol (Cholesta-5,7-dien-3-beta-ol) | 434-16-2 | C27H44O | 384.65 |
7-Dehydro Desmosterol | 1715-86-2 | C27H42O | 382.64 |
7-Dehydro Desmosterol-d6 | N/A | C27H36OD6 | 388.67 |
Desmosterol-D6 | C27H38D6O | 390.69 | |
Cholesterol-d4 | C27H42OD4 | 390.69 | |
Cholesterol-d6 | C27H40OD6 | 392.71 | |
4-Hydroxy Cholesterol | C27H46O2 | 402.67 | |
4-beta-Hydroxy Cholesterol-d7 | 1246302-80-6 | C27H39O2D7 | 409.71 |
27-Hydroxy 7-ketocholesterol | C27H44O3 | 416.65 | |
27-Hydroxy 7-ketocholesterol-d10 | C27H34O3D10 | 426.71 | |
27-Carboxy 7-Ketocholesterol | C27H42O4 | 430.63 | |
27-Carboxy 7-Ketocholesterol-d10 | C27H32O4D10 | 440.69 | |
Cyclosporine | C62H111N11O12 | 1202.64 | |
Cyclosporin D | 63775-96-2 | C63H113N11O12 | 1216.67 |
Cotinine | C10H12N2O | 176.22 | |
Trans 3-hydroxy cotinine-D3 | C10H9N2O2D3 | 195.24 | |
Norcotinine | C9H10N2O | 162.19 | |
Norcotinine N-Oxide | C9H10N2O2 | 178.19 | |
Cotinine-d4 | 110952-70-0 (non-d) | C10H8N2OD4 | 180.24 |
Cotinine-d7 | 15569-85-4 (non-labelled) | C10H5N2OD7 | 183.28 |
Cotinine N-Oxide | C10H12N2O2 | 192.22 | |
Cotinine N-glucuronide | C16H20N2O7 | 352.35 | |
Cotinine-d3 | 110952-70-0(non-d) | C10H9N2OD3 | 179.24 |
Trans 3-hydroxy cotinine | C10H12N2O2 | 192.22 | |
Lysine Clonixinate | 55837-30-4 | C13H11ClN2O2. C6H14N2O2 | 262.70 146.19 |
Clonixin | 17737-65-4 | C13H11ClN2O2 | 262.7 |
Clonixin-D6 | C13H5ClN2O2D6 | 268.73 | |
Cholic-2,2,4,4-D4 Acid | C24H36O5D4 | 412.61 | |
Glycochenodeoxycholic acid-d4 | N/A | C26H39NO5D4 | 453.66 |
Cholic Acid Impurity (3-alpha-Hydroxy-7,12-diketo-5-beta-cholan-24-oic acid) | 517-33-9 | C24H36O5 | 404.55 |
3-Oxo Deoxycholic Acid | 2304-89-4 | C24H38O5 | 406.57 |
12-Oxochenodeoxycholic Acid | 04-08-2458 | C24H38O5 | 406.57 |
Cholic Acid Impurity (3-alpha-Hydroxy-12-Oxo-5-beta-Cholanoic Acid) | 5130-29-0 | C24H38O4 | 390.57 |
Cholic acid impurity, 1,3,7-trihydroxyl-cholanic acid | C24H40O5 | 408.58 | |
Cholic Acid Impurity (3,7,22-Trihydroxyl-Cholanic Acid) | 108266-90-6 | C24H40O5 | 408.58 |
Ursocholic acid | 2955-27-3 | C24H40O5 | 408.58 |
Cholic Acid Impurity (5-beta-Cholane-3-alpha-7-beta-24-Triol) | 130593-75-8 | C24H42O3 | 378.6 |
Isoursodeoxycholic Acid | 78919-26-3 | C24H40O4 | 392.58 |
Taurocholic-2,2,4,4-D4 Acid | C26H41NO7SD4 | 519.74 | |
Taurocholic Acid | C26H45NO7S | 515.72 | |
Cholic Acid | C24H40O5 | 408.58 | |
Taurodeoxycholic acid | 516-50-7 | C26H45NO6S | 499.72 |
Taurodeoxycholic acid-d4 | N/A | C26H41NO6SD4 | 503.74 |
Glycocholic acid | 475-31-0 | C26H43NO6 | 465.64 |
Glycocholic acid-d4 | N/A | C26H39NO6D4 | 469.66 |
Glycochenodeoxycholic acid | 640-79-9 | C26H43NO5 | 449.64 |
alpha-Cypermethrin | C22H19Cl2NO3 | 416.31 | |
Choline Citrate | 3(C5H14NO)̢ۢC6H5O7 | 3 104.17̢ۢ189.10 | |
Choline Dihydrogen Citrate | 77-91-8 | C5H14NO.C6H7O7 | 104.17 191.12 |
Phosphocholine-d9 | C5H5NO4PD9 | 192.2 | |
DPPC (Dipalmitoylphosphatidylcholine) | 2644-64-6 | C40H80NO8P | 734.06 |
Uridine Diphosphate Choline (UDPC) | 99492-83-8 | C14H25N3O12P2 | 489.32 |
Citicoline Sodium Salt (CDP-Choline) | 33818-15-4 | C14H25N4O11P2. Na | 487.32 22.99 |
Carprofen | 53716-49-7 | C15H12ClNO2 | 273.72 |
Chlorambucil | 305-03-3 | C14H19Cl2NO2 | 304.22 |
Chlorambucil-d8 | 305-03-3 (non-d) | C14H11Cl2NO2D8 | 312.27 |
Phenylacetic acid mustard | 10477-72-2 | C12H15Cl2NO2 | 276.16 |
Phenylacetic acid mustard-d8 | 10477-72-2 (non-d) | C12H7Cl2NO2D8 | 284.21 |
3,4-Dehydrochlorambucil | N/A | C14H17Cl2NO2 | 302.2 |
Clocinizine | 298-55-5 | C26H27ClN2 | 402.97 |
Clocinizine-d8 | 298-55-5 (non-d) | C26H19ClN2D8 | 411.04 |
Carisoprodol-d3 | 78-44-4 (non-d) | C12H21N2O4D3 | 263.35 |
Carisoprodol | 78-44-4 | C12H24N2O4 | 260.34 |
Carisoprodol-d7 | C12H17N2O4D7 | 267.38 | |
Carisoprodol impurity B | 7148-50-7 | C8H14O3 | 158.2 |
Carisoprodol impurity C | 78-26-2 | C7H16O2 | 132.2 |
Carisoprodol isopropyl impurity | 1729-14-2 | C15H30N2O4 | 302.42 |
Carisbamate (RWJ-333369) | 194085-75-1 | C9H10ClNO3 | 215.64 |
Carisbamate-15N-13C-d2 | 194085-75-1 (non labeled) | C9H8ClNO3D2 | 219.63 |
Carisbamate glucuronide (mixture of diasteromers) | N/A | C15H18ClNO9 | 391.77 |
R-Carisbamate (RWJ-452399) | C9H10ClNO3 | 215.64 | |
R-Carisbamate-15N-13C-d2 | C9H8ClNO3D2 | 219.63 | |
R-Carisbamate glucuronide (mixture of diasteromers) | C15H18ClNO9 | 391.77 | |
Carisbamate-d4 | 1292841-50-9 | C9H6ClNO3D4 | 219.66 |
Chlormadinone Acetate | 302-22-7 | C23H29ClO4 | 404.94 |
3-Hydroxy Chlormadinone Acetate-d3 | C22H26ClO4D3 | 395.95 | |
3-Hydroxy Chlormadinone Acetate-13C-d3 | C22H26ClO4D3 | 397.92 | |
Chlormadinone-d6 Acetate | C23H23ClO4D6 | 410.97 | |
Chlormadinone | 1961-77-9 | C21H27ClO3 | 362.9 |
Chlormadinone-d7 | C21H20ClO3D7 | 369.94 | |
Chlormadinone-d7 Acetate | C23H22ClO4D7 | 411.98 | |
Chlormadinone Acetate-d3 | C23H26ClO4D3 | 407.96 | |
Chlormadinone Acetate-13C-d3 | C23H26ClO4D3 | 409.93 | |
3-Hydroxy Chlormadinone | C20H27ClO3 | 350.89 | |
3-Hydroxy Chlormadinone-d5 | C21H24ClO3D5 | 369.95 | |
3-Hydroxy Chlormadinone Acetate | 17184-15-5 | C22H29ClO4 | 392.93 |
Cefaclor-d5 | C15H9ClN3O4SD5 | 372.84 | |
Cefaclor | 53994-73-3 | C15H14ClN3O4S | 367.81 |
Cefaclor impurity E | C14H14ClN3O4S | 355.8 | |
Cefaclor Delta-3-Isomer | N/A | C15H14ClN3O4S | 367.81 |
Cefaclor Impurity C | 143059-69-2 | C15H14ClN3O4S | 367.81 |
Carbinoxamine-d6 Maleate | 3505-38-2 (non-labelled) | C16H13ClN2OD6.C4H4O4 | 296.83 116.07 |
Carbinoxamine | 486-16-8 | C16H19ClN2O | 290.8 |
Carbinoxamine Impurity A | 27652-89-7 | C12H10ClNO | 219.67 |
Carbinoxamine Impurity B | 14159-57-0 | C12H11NO | 185.23 |
Ciprofibrate | 52214-84-3 | C13H14Cl2O3 | 289.16 |
Ciprofibrate-d6 | N/A | C13H8Cl2O3D6 | 295.2 |
Ciprofibrate-O-Belta-D-Glucuronide | N/A | C19H22Cl2O9 | 465.29 |
Ciprofibrate impurity A | C12H14O3 | 206.24 | |
Ciprofibrate impurity B | C9H8Cl2O | 203.07 | |
Ciprofibrate impurity C | C13H16Cl2O2 | 275.18 | |
Ciprofibrate impurity D | C14H16Cl2O3 | 303.19 | |
Ciprofibrate impurity E | C15H18Cl2O3 | 317.21 | |
Curcumin | C21H20O6 | 368.39 | |
Curcumin-d6 | C21H14O6D6 | 374.43 | |
Curcumin Glucuronide | C27H28O12 | 544.52 | |
Curcumin Sulfate | 339286-19-0 | C21H19O9S C16H36N | 447.44 242.47 |
Curcumin Sulfate Sodium Salt | 339286-19-0 | C21H18O9S. 2 Na | 446.44 2 22.99 |
Campesterol (mixture of isomers) | C28H48O | 400.69 | |
Coenzyme Q10 | 303-98-0 | C59H90O4 | 863.37 |
Coenzyme Q10-d5 | 303-98-0 (non-labelled) | C59H85O4D5 | 868.4 |
Coenzyme Q10-d6 | 303-98-0 (non-labelled) | C59H84O4D6 | 869.41 |
DL-Carnitine HCl | 461-05-2 | C7H15NO3.HCl | 161.20 36.46 |
L-(-)-Carnitine | 541-15-1 | C7H15NO3 | 161.2 |
(S)-7-Ethyl-10-Hydroxy Camptothecin | C22H20N2O5 | 392.42 | |
7-Ethyl-10-Hydroxy Camptothecin-d3 | N/A | C22H17N2O5D3 | 395.45 |
7-Ethyl-10-Hydroxy Camptothecin-d5 | 718612-51-2 | C22H15N2O5D5 | 397.45 |
7-Ethyl Camptothecin | 78287-27-1 | C22H20N2O4 | 376.42 |
10-Hydroxy Camptothecin | 19685-09-7 | C20H16N2O5 | 364.36 |
7,11-Diethyl-10-hydroxycamptothecin | 947687-01-6 | C24H24N2O5 | 420.47 |
(R)-7-Ethyl-10-Hydroxy Camptothecin | C22H20N2O5 | 392.42 | |
(rac)-7-Ethyl-10-Hydroxy Camptothecin | C22H20N2O5 | 392.42 | |
Clobutinol HCl | 1215-83-4 | C14H22ClNO.HCl | 255.79 36.46 |
Clofazimine | 2030-63-9 | C27H24Cl2N4 | 475.43 |
Clofazimine-d7 | 2030-63-9 (non-d) | C27H17Cl2N4D7 | 482.47 |
Clofazimine Related Compound B | C27H23ClN4 | 438.96 | |
Cefditoren Sodium Salt | 104146-53-4 | C19H17N6O5S3.Na | 505.58 22.99 |
Cefditoren impurity 9, dimer | C51H56N12O14S6 | 1253.47 | |
Cefditoren impurity 10, ring open dimer | C51H59N13O14S6 | 1270.5 | |
Cefditoren | 104145-95-1 | C19H18N6O5S3 | 506.58 |
Cefditoren Impurity P4 | C27H32N6O8S3 | 664.78 | |
Cefditoren Impurity P14 | C31H38N6O9S3 | 734.88 | |
Cefditoren Dimer Impurity P16 | C50H56N12O14S6 | 1241.46 | |
Cefditoren-d3 | C19H15N6O5S3D3 | 509.6 | |
Cefditoren Pivoxil | 117467-28-4 | C25H28N6O7S3 | 620.73 |
Cefditoren impurity 2, Cefditoren open ring | C25H30N6O8S3 | 638.74 | |
Cefditoren impurity 4, cefditoren △-3 isomer | C25H28N6O7S3 | 620.72 | |
Cefditoren impurity 5, cefditoren, methoxymethyl | C27H32N6O8S3 | 664.77 | |
Cefditoren impurity 6, cefditoren E-isomer(C=C) | C25H28N6O7S3 | 620.72 | |
Cefditoren impurity 7, cefditoren dipivoxil | C31H38N6O9S3 | 734.86 | |
Cefditoren impurity 8, cefditorenPivaloyl | C30H36N6O8S3 | 704.84 | |
N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)cysteine | C8H14N2O5S | 250.28 | |
Acetylcysteine Impurity C | C10H16N2O6S2 | 324.38 | |
S-Carboxypropyl-L- Cysteine-(R)-Sulfoxide | N/A | C7H13NO5S | 223.25 |
S-Carboxypropyl-L- Cysteine-(S)-Sulfoxide | N/A | C7H13NO5S | 223.25 |
Acetylcysteine Impurity A (L-Cystine) | 56-89-3 | C6H12N2O4S2 | 240.3 |
Acetylcysteine Impurity D | C7H11NO4S | 205.23 | |
Acetylcysteine Impurity B (L-Cysteine) | 52-90-4 | C3H7NO2S | 121.16 |
S-(1,2-Dichlorovinyl)-Cysteine | C5H7Cl2NO2S | 216.09 | |
S-(1,2-dichlorovinyl) cysteine-13C3-15N | C5H7Cl2NO2S | 220.05 | |
S-Carboxymethyl L-Cysteine Sulfoxide Lactam | NA | C5H7NO4S | 177.18 |
S-Carboxymethyl L-Cysteine Sulfoxide | 5439-87-2 | C5H9NO5S | 195.2 |
S-Carboxymethyl L-cysteine Lactam | 62305-89-9 | C5H7NO3 | 161.18 |
S-Methyl-L-Cysteine-S-oxide | 6853-87-8 | C5H11NO3S | 165.21 |
Cefoperazone Impurity A | 73240-08-1 | C23H23N5O8S | 529.53 |
Cefoperazone Impurity C | C2H4N4S | 116.14 | |
Cefoperazone Sodium | C25H26N9O8S2.Na | 644.67 22.99 | |
Cefoperazone Impurity B | 711590-76-4 | C25H26N9O8S2 | 644,67 |
Cefoperazone Impurity F | 1315481-36-7 | C25H29N9O8S2 | 647.69 |
Cefoperazone Impurity D | 37539-03-0 | C10H11N5O3S2 | 313.36 |
Cabergoline Impurity D | N/A | C23H32N4O | 380.54 |
Cabergoline Impurity A | N/A | C18H20N2O2 | 296.37 |
Cabergoline | 81409-90-7 | C26H37N5O2 | 451.62 |
Cabergoline isomer | C26H37N5O2 | 451.62 | |
Clioquinol EP Impurity A (Cloxyquin) | 130-16-5 | C9H6ClNO | 179.61 |
Clioquinol EP Impurity B | 773-76-2 | C9H5Cl2NO | 214.05 |
Clioquinol EP Impurity C | 83-73-8 | C9H5I2NO | 396.96 |
Clevidipine | 167221-71-8 | C21H23Cl2NO6 | 456.33 |
Clevidipine Impurity 7 | 91854-02-3 | C16H13Cl2NO4 | 354.19 |
Clevidipine-d7 | C21H16Cl2NO6D7 | 463.37 | |
Clevidipine Impurity 1 | C16H15Cl2NO4 | 356.21 | |
Clevidipine Impurity 2 | C25H29Cl2NO8 | 542.42 | |
Clevidipine Impurity 3 | C17H17Cl2NO4 | 370.24 | |
Clevidipine Impurity 4 | C15H15Cl2NO2 | 312.2 | |
Clevidipine Impurity 5 | C21H21Cl2NO6 | 454.31 | |
Clevidipine Impurity 6 | C15H13Cl2NO4 | 342.18 | |
Clevidipine isomer | C21H23Cl2NO6 | 456.33 | |
Cis-clomiphene (Zuclomiphene) | 15690-55-8 | C26H28ClNO | 405.97 |
Trans-clomiphene (enclomiphene) | 15690-57-0 | C26H28ClNO | 405.97 |
Trans-clomiphene-d5 (enclomiphene-d5) | C26H23ClNOD5 | 411 | |
Clomiphene-N-Oxide | C26H28ClNO2 | 421.97 | |
3-Chloroclomiphene Citrate | N/A | C26H27Cl2NO C6H8O7 | 440.42 192.13 |
Deschloro Clomiphene | 19957-52-9 | C26H29NO | 371.53 |
Cefpodoxime acid | C15H17N5O6S2 | 427.46 | |
Cefpodoxime Proxetil Impurity I | C25H33N5O11S2 | 643.7 | |
Cefpodoxime Proxetil Impurity J | C21H27N5O10S2 | 573.6 | |
Cefpodoxime Proxetil Impurity K | C21H27N5O10S2 | 573.6 | |
Cefpodoxime-d3 acid | C15H14D3N5O6S2 | 430.47 | |
Cefpodoxime Proxetil Impurity B | 947692-14-0 | C20H25N5O8S2 | 527.58 |
Cefpodoxime Proxetil Impurity C | C21H27N5O9S2 | 557.61 | |
Cefpodoxime Proxetil Impurity D | 947692-13-9 | C21H27N5O9S2 | 557.61 |
Cefpodoxime Proxetil Impurity E | 217803-89-9 | C22H27N5O10S2 | 585.62 |
Cefpodoxime Proxetil Impurity F | C22H27N5O10S2 | 585.62 | |
Cefpodoxime Proxetil Impurity G | 947692-15-1 | C23H29N5O10S2 | 599.64 |
Cefpodoxime Proxetil (Mixture of Diastereomers) | 87239-81-4 | C21H27N5O9S2 | 557.61 |
Ceftiofur HCl | C19H17N5O7S3.HCl | 523.57 36.46 | |
Ceftiofur-d3 | C19H14N5O7S3D3 | 526.59 | |
Desfuroyl Ceftiofur | 120882-22-6 | C14H15N5O5S3 | 429.5 |
trans-Capsaicin | 404-86-4 | C18H27NO3 | 305.42 |
17-Hydroxy Capsaicin | 69173-71-3 | C18H27NO4 | 321.42 |
Nordihydrocapsaicin | 28789-35-7 | C17H27NO3 | 293.41 |
trans-Capsaicin-d3 | 1217899-52-9 | C18H24NO3D3 | 308.44 |
trans-Capsaicin-13C-d3 | C18H24NO3D3 | 309.43 | |
cis-Capsaicin | 25775-90-0 | C18H27NO3 | 305.42 |
cis-Capsaicin-d3 | 1004316-88-4 (non-labelled) | C18H24NO3D3 | 308.44 |
cis-Capsaicin-13C-d3 | C18H24NO3D3 | 309.43 | |
Dihydro Capsaicin | 19408-84-5 | C18H29NO3 | 307.44 |
16,17-Dehydro Capsaicin | 509101-57-9 | C18H25NO3 | 303.4 |
16-Hydroxy Capsaicin | 112848-19-8 | C18H27NO4 | 321.42 |
Cefditoren impurity 3, Cefetamet Pivoxil | 65243-33-6 | C20H25N5O7S2 | 511.58 |
Delta-2-Cefetamet Pivoxil | 126617-54-7 | C20H25N5O7S2 | 511.58 |
(E)-Cefetamet Pivoxil | C20H25N5O7S2 | 511.58 | |
Cefetamet | 65052-63-3 | C14H15N5O5S2 | 397.43 |
Cefteram | 82547-58-8 | C16H17N9O5S2 | 479.5 |
d2-Cefteram | 104691-34-1 | C16H17N9O5S2 | 479.5 |
Cefteram Pivoxil | 82547-81-7 | C22H27N9O7S2 | 593.64 |
Delta-2-Cefteram Pivoxil | 104712-44-9 | C22H27N9O7S2 | 593.64 |
Ceftizoxime | C13H13N5O5S2 | 383.41 | |
Ceftizoxime Impurity (Double Bond 2-isomer) | C13H13N5O5S2 | 383.41 | |
Ceftizoxime Impurity (Z isomer Ring –Opening) | C13H15N5O6S2 | 401.42 | |
Ceftizoxime S-oxide impurity | C13H13N5O6S2 | 399.41 | |
E-Ceftizoxime Sodium Salt | 97164-53-9 | C13H12N5O5S2. Na | 382.40 22.99 |
Ceftizoxime Impurity 1 | C20H19N7O7S3 | 565.61 | |
Ceftizoxime Impurity 2 | C19H18N8O7S3 | 566.6 | |
Ceftizoxime Impurity 3 | C13H15N5O6S2 | 401.42 | |
Ceftizoxime Impurity 4 | C13H15N5O6S2 | 401.42 | |
Ceftizoxime Impurity 5 | C13H15N5O5S2 | 385.42 | |
Ceftizoxime Related Compound (4-Hydroxyphenylglycine Methyl Ester HCl) | C9H11NO3.HCl | 181.19 36.46 | |
Cefixime | C16H15N5O7S2 | 453.46 | |
Cefixime methyl ester | 88621-01-6 | C17H17N5O7S2 | 467.48 |
Cefixime-13C-15N2 | NA | C16H15N5O7S2 | 456.43 |
Cefixime-13C3-15N2 | NA | C16H15N5O7S2 | 458.41 |
Cefixime Impurity F | 79368-95-9 | C18H19N5O7S2 | 481.51 |
Cefixime impurity A | C16H17N5O8S2 | 471.47 | |
Cefixime impurity B | C15H17N5O6S2 | 427.46 | |
Cefixime EP Impurity C (Cefixime 7-epimer) | 108691-83-4 | C16H15N5O7S2 | 453.46 |
Cefixime impurity D | C16H15N5O7S2 | 453.46 | |
Cefixime impurity E | C15H15N5O7S2 | 441.44 | |
Chloroquine Dihydrochloride | 3545-67-3 | C18H28Cl3N3 | 392.79 |
Chloroquine-d5 Diphosphate | 5-67-3 (non-d) | C18H21ClN3D5. 2 H3O4P | 324.91 2 98.00 |
Desethyl Chloroquine-d4 | 1476-52-4 (non-d) | C16H18ClN3D4 | 295.85 |
Desethyl Chloroquine | 1476-52-4 | C16H22ClN3 | 291.83 |
Didesethyl Chloroquine | 4298-14-0 | C14H18ClN3 | 263.77 |
Didesethyl Chloroquine-d4 | 4298-14-0 (non-d) | C14H14ClN3D4 | 267.8 |
Desethyl Chloroquine-d5 HCl | C16H17ClN3D5.HCl | 296.86 36.46 | |
Ceftriaxone-d3 | C18H15N8O7S3D3 | 557.6 | |
(E)-Ceftriaxone (Impurity A) | C18H18N8O7S3 | 554.59 | |
Ceftriaxone Impurity B | 66340-33-8 | C14H13N5O5S2 | 395.42 |
Ceftriaxone Impurity C | C4H5N3O2S | 159.17 | |
Ceftriaxone Impurity D | 80756-85-0 | C13H10N4O2S3 | 350.44 |
Ceftriaxone Impurity E | 58909-56-1 | C12H13N5O5S2 | 371.4 |
Cabazitaxel-d6 | C45H51NO14D6 | 841.99 | |
(2̢۪S, 3̢۪R)-Cabazitaxel | N/A | C45H57NO14 | 835.95 |
Cabazitaxel | 183133-96-2 | C45H57NO14 | 835.95 |
Cabazitaxel Impurity (DiTroc) | C35H38Cl6O14 | 895.4 | |
Cabazitaxel Impurity (DiTroc-oxazolidine) | C52H59Cl6NO18 | 1198.76 | |
Cabazitaxel Impurity (DeTroc-oxazolidine) | C46H57NO14 | 847.97 | |
Cabazitaxel Impurity (Amine) | C40H49NO12 | 735.84 | |
Cabazitaxel Impurity (Oxazolidine Protected) | C48H61NO14 | 876.02 | |
Cabazitaxel Impurity | 183133-94-0 | C31H40O10 | 572.66 |
Cabazitaxel Impurity (4-Deacetyl-4-Propionyl-Cabazitaxel) | N/A | C46H59NO14 | 849.98 |
Cytosine-13C-15N2 | C313CH515N2NO | 114.08 | |
Cefazolin | 25953-19-9 | C14H14N8O4S3 | 454.51 |
Cefazolin Impurity (1H-Tetrazole-1-acetic acid) | 21732-17-2 | C3H4N4O2 | 128.09 |
Cefazolin Impurity A | 30246-33-4 | C11H12N4O3S3 | 344.44 |
Cefazolin Impurity D | 32510-61-5 | C13H14N6O6S | 382.36 |
Cefazolin Impurity C | 56842-77-4 | C11H12N6O4S | 324.32 |
Cefazolin 3-Hydroxymethyl Impurity | N/A | C11H12N6O5S | 340.32 |
Cefazolin delta-4 Impurity | N/A | C11H16N8O5S3 | 472.53 |
Tetrazolyl Acetamide Acetal | N/A | C5H9N5O3 | 187.16 |
Cefazolin Impurity 1 | C13H17N3O7S | 359.36 | |
Cefazolin Impurity 2 | C13H17N3O6S | 343.36 | |
Cefazolin Impurity K | Cefazolin Impurity K | 453.53 | |
Cefazolin Impurity I | C14H16N8O5S3 | 472.53 | |
Cefazolin Impurity J | C11H14N6O6S | 358.33 | |
Cefazolin-d2-15N | C14H12N8O4S3D2 | 457.52 | |
Cefazolin-13C2-15N | C12H14N7O4S313C215N | 457.48 | |
Cefazolin Sodium impurity B | C16H20N4O4S3 | 428.55 | |
Cefazolin Sodium impurity G | C11H10N6O4S | 322.3 | |
Cefazolin Impurity E | 29490-19-5 | C3H4N2S2 | 132.21 |
Carbasalate Calcium Impurity A | C18H14O7 | 342.31 | |
Carbasalate Calcium Impurity D | C14H10O5 | 258.23 | |
Carbasalate Calcium | 5749-67-7 | 2 C9H7O4 CH4N2O Ca | 2 179.15 60.06 40.08 |
Clethodim sulfoxide | 111031-14-2 | C17H26ClNO4S | 375.92 |
Clethodim Sulfone | C17H26ClNO5S | 391.92 | |
Clethodim | 99129-21-2 | C17H26ClNO3S | 359.92 |
Z-Clethodim | N/A | C17H26ClNO3S | 359.92 |
Clophedianol | 791-35-5 | C17H20ClNO | 289.81 |
Clophedianol-d5 | C17H15ClNOD5 | 394.84 | |
Clophedianol-D-glucuronide | 66171-85-5 | C23H28ClNO7 | 465.94 |
Dapsone-d8 | NULL | C12H4N2O2SD8 | 256.35 |
Dapsone hydroxylamine | 32695-27-5 | C12H12N2O3S | 264.3 |
Monoacetyl Dapsone | C14H14N2O3S | 290.34 | |
2-Hydroxy Desipramine | 1977-15-7 | C18H22N2O | 282.39 |
2-Hydroxy desipramine-d6 HCl | 59259-75-5(non-d) | C18H16D6N2O.HCl | 324.89 |
2-Hydroxy desipramine glucuronide | 25521-31-7 | C24H30N2O7 | 456.54 |
2-Hydroxy desipramine-d6 glucuronide | 25521-31-7(non-d) | C24H24D6N2O7 | 462.58 |
Desipramine-d4 HCl | 61361-34-0 | C18H18N2D4.HCl | 270.41 36.46 |
Desipramine HCl | 58-28-6 | C18H22N2 HCl | 266.39 36.46 |
N-(3-Dimethylaminopropyl)desipramine DiHCl | 1838-02-4 | C23H33N3 2 HCl | 351.54 2 36.46 |
Dextromethorphan-d3 HBr | 127-71-3 | C18H22D3NO.HBr | 355.33 |
Dextromethorphan HBr | 125-69-9 | C18H25NO. HBr | 271.41 80.91 |
Dextromethorphan Impurity B | C17H23NO | 257.38 | |
10-beta-Hydroxydextromethorphan | C18H25NO2 | 287.41 | |
10-alpha-Hydroxydextromethorphan | C18H25NO2 | 287.41 | |
N-Formyl Octabase | C18H23NO2 | 285.39 | |
N-Formyl Morphnan | C18H23NO2 | 285.39 | |
Dextrorphan-d3 tartrate | C17H20NOD3.C4H6O6 | 260.40 150.09 | |
Dextrorphan tartrate | C17H23NO.C4H6O6 | 257.38 150.09 | |
Dextrorphan O-Glucuronide | 19153-87-8 | C23H31NO7 | 433.51 |
Diclofenac-d4 | 153466-65-0 | C14H7D4Cl2NO2 | 300.18 |
Diclofenac Lactam (Diclofenac Impurity A) | C14H9Cl2NO | 278.14 | |
Diclofenac Diethylamine | C18H20Cl2N2O2 | 367.28 | |
Diclofenac Dimer Impurity | N/A | C28H22Cl4N2O4 | 592.31 |
Diclofenac Related Compound (Alpha-(2,6-Dichlorophenyl)-4-Chloroacetanilide) | 560075-65-2 | C14H10Cl3NO | 314.6 |
Diclofenac 2,5-Quinone Imine | 1254576-93-6 | C14H9Cl2NO3 | 310.14 |
2,6-Dichloroquinone-4-chloroimide (Gibb's Reagent) | 101-38-2 | C6H2Cl3NO | 210.45 |
2,6-Dichlorodiphenylamine | 15307-93-4 | C12H9Cl2N | 238.12 |
Diclofenac Related Compound (N-Chloroacetyl-N-phenyl-2,6-dichloroaniline) | 15308-01-7 | C14H10Cl3NO | 314.6 |
4' -Hydroxy diclofenac | 64118-84-9 | C14H11Cl2NO3 | 312.15 |
4-Hydroxy Diclofenac-d4 | 254762-27-1 | C14H7D4Cl2NO3 | 316.18 |
Diclofenac-acyl-beta-D-glucuronide | 64118-81-6 | C20H19Cl2NO8 | 472.28 |
Diclofenac | 15307-86-5 | C14H11Cl2NO2 | 296.16 |
Diclofenac Impurity B | C13H9Cl2NO | 266.13 | |
Diclofenac Impurity C | C13H11Cl2NO | 268.14 | |
Diclofenac Impurity D | C14H11BrClNO2 | 340.61 | |
Diclofenac Impurity E | 59-48-3 | C8H7NO | 133.15 |
Diltiazem HCl | 33286-22-5 | C22H26N2O4S.HCl | 450.99 |
N,N,O-Tridesmethyl Desacetyl Diltiazem | C17H18N2O3S | 330.41 | |
Diltiazem Impurity B | 87447-47-0 | C18H17NO4S | 343.4 |
Diltiazem Impurity C HCl (O-Desmethyl Diltiazem HCl) | 84903-78-6 (free base) | C21H24N2O4S . HCl | 400.50 36.46 |
Diltiazem Impurity E | 42399-49-5 | C16H15NO3S | 301.37 |
Diltiazem impurity A (2-Epi isomer) | C22H26N2O4S | 414.53 | |
Diltiazem-d3 HCl | C22H23N2O4SD3.HCl | 417.55 36.46 | |
N-Desmethyl diltiazem HCl | 130606-60-9 | C21H24N2O4S. HCl | 400.50 36.46 |
Desacetyl diltiazem HCl | 75472-91-2 | C20H24N2O3S.HCl | 408.95 |
Diltiazem-d4 HCl | NULL | C22H22N2O4SD4.HCl | 418.55 36.46 |
Desacetyl Diltiazem-d3 HCl | NULL | C20H21N2O3SD3.HCl | 375.51 36.46 |
Desacetyl Diltiazem-d4 HCl | NULL | C20H20N2O3SD4.HCl | 376.51 36.46 |
Desmethyl Diltiazem-d4 HCl | C21H20N2O4SD4.HCl | 404.52 36.46 | |
N-Desmethyl Desacetyl Diltiazem HCl | C19H22N2O3S.HCl | 358.46 36.46 | |
diphenhydramine-d3 | C17H18D3NO | 258.34 | |
diphenhydramine-d3 | C17H18D3NO | 258.34 | |
Diphenhydramine Impurity K | C26H22O | 350.46 | |
Diphenhydramine Methiodide | C18H24NO . I | 270.40 126.90 | |
Diphenhydramine Related Compound [3-(Benzyhdryloxy)propane-1,2-diol] | 19574-66-4 | C16H18O3 | 258.32 |
Diphenhydramine Impurity B HCl | 4024-34-4 | C18H23NO. HCl | 269.39 36.46 |
Dipenhyldramine-d4 HCl | C17H17NOD4 . HCl | 259.39 36.46 | |
Diphenhydramine-d5 | C17H16NOD5 | 260.39 | |
Diphenhydramine N-Glucuronide | C23H29NO7 | 431.49 | |
Dequalinium Impurity A | C10H10N2 | 158.2 | |
Dequalinium Impurity B | C30H39N4 . Cl | 455.67 35.45 | |
Dequalinium Impurity C | C50H69N6 . 3 Cl | 754.15 3 35.45 | |
Dequalinium Chloride | 522-51-0 | C30H40N4. 2 Cl | 456.68 2 35.45 |
Diphenhydramine N-Oxide | 3922-74-5 | C17H21NO2 | 271.36 |
Dicycloverine (Dicyclomine) | 77-19-0 | C19H35NO2 | 309.5 |
Dicycloverine-d4 | N/A | C19H31NO2D4 | 313.52 |
Dicycloverine Impurity A | C13H22O2 | 210.32 | |
Diphenhydramine-d5 HCl | 1219795-16-0 | C17H16NOD5.HCl | 260.39 36.46 |
Dimetridazole-d3 | 64678-69-9 | C5H4N3O2D3 | 144.15 |
Dimetridazole | 551-92-8 | C5H7N3O2 | 141.13 |
Diphenhydramine HCl | C17H21NO. HCl | 255.36 36.46 | |
Dofetilide | 115256-11-6 | C19H27N3O5S2 | 441.57 |
Dofetilide-d4 | C19H23N3O5S2D4 | 445.6 | |
Diphenhydramine Impurity A HCl | 53499-40-4 | C16H19NO HCl | 241.34 36.46 |
Drotaverine HCl | 985-12-6 | C24H31NO4 HCl | 397.52 36.46 |
Diphenhydramine Impurity C HCl | 1808-12-4 | C17H20BrNO. HCl | 334.26 36.46 |
Deferoxamine Mesylate Impurity 1 | N/A | C18H34N4O7 | 418.49 |
Deferoxamine Mesylate Impurity 2 | N/A | C23H46N6O6 | 502.66 |
Deferoxamine-D3 mesylate | C25H45N6O8D3 . CH4O3S | 563.71 96.11 | |
5-Amino-4-Imidazolecarboxamide HCl | N/A | C4H6N4O HCl | 126.12 36.46 |
Dacarbazine Impurity A (3,7-Dihidro-4H-Imidazo[4,5-d][1,2,3]triazin-4-One) | 4656-86-4 | C4H3N5O | 137.1 |
Dacarbazine Impurity C | C4H5N5O | 139.12 | |
Diquat-d4 dibromide | 85-00-7(non-d) | C12H8D4N2.2Br | 348.07 |
Nor-Desoxycholic Acid | 53608-86-9 | C23H38O4 | 378.56 |
Deterenol | 7376-66-1 | C11H15NO2 | 193.25 |
Dolutegravir | 1051375-16-6 | C20H19F2N3O5 | 419.39 |
Dolutegravir-d5 | C20H14F2N3O5D5 | 424.42 | |
Diazepam Impurity B | 6021-21-2 | C16H13Cl2NO2 | 322.19 |
Diazepam Impurity E | 20927-53-1 | C15H11ClN2O | 270.72 |
Diazepam Impurity F | 31269-33-7 | C16H13ClN2O | 284.75 |
Diaveridine | 5355-16-8 | C13H16N4O2 | 260.3 |
Dimethindene Impurity H (2-[(1RS)-1-(2-ethenyl-1H-Inden-3-yl)ethyl]pyridine) | 1346597-95-2 | C18H17N | 247.34 |
Dimethindene | 5636-83-9 | C20H24N2 | 292.43 |
Dimethindene Impurity F | C17H25N | 243.4 | |
Dimethindene Impurity G | C19H21N | 263.39 | |
Dimethindene Impurity I | C19H22N2 | 278.4 | |
Dolasetron | 115956-12-2 | C19H20N2O3 | 324.38 |
Dolasetron-d4 | N/A | C19H16N2O3D4 | 328.41 |
Hydrodolasetron | 127951-99-9 | C17H22N2O3 | 326.4 |
Hydrodolasetron-d4 | 127951-99-9 (non-labelled) | C19H18N2O3D4 | 330.42 |
Diglyme (2-Methoxyethyl Ether) | 111-96-6 | C6H14O3 | 134.18 |
Droperidol Impurity A | C12H13N3O | 215.26 | |
Droperidol Impurity B | C22H22FN3O2 | 379.44 | |
Droperidol Impurity C | C22H19FN3O2 . Cl | 376.41 35.45 | |
Droperidol Impurity D | C22H22FN3O3 | 395.44 | |
Droperidol Impurity E | C34H34N6O3 | 574.69 | |
Danofloxacin Mesylate | 119478-55-6 | C20H21FN2O3 . CH4O3S | 356.40 96.11 |
Docusate Sodium Related Compound B | C12H20O7S . 2 Na | 308.35 2 22.99 | |
Decoquinate-D5 | C24H30NO5D5 | 422.58 | |
Diphenylamine | 122-39-4 | C12H11N | 169.23 |
Dalotutumab (Renzapride) | 109872-41-5 | C16H22ClN3O2 | 323.83 |
Dalotutumab (Renzapride)-13CD3 | C16H19ClN3O2D3 | 327.83 | |
Dirithromycin | 62013-04-1 | C42H78N2O14 | 835.09 |
Dirithromycin-13C-D3 | C42H75N2O14D3 | 839.1 | |
Dirithromycin Impurity B | C29H56N2O9 | 576.78 | |
Dirithromycin Impurity C | C41H76N2O13 | 805.07 | |
Deslorelin acetate | 82318-06-7 | C64H83N17O12 . C2H4O2 | 1282.48 60.05 |
Dabrafenib | 1195765-45-7 | C23H20F3N5O2S2 | 519.57 |
Dabrafenib-D9 | 1423119-98-5 | C23H11F3N5O2S2D9 | 528.63 |
Diphemanil Methylsulfate | 62-97-5 | C20H24N. CH3O4S | 278.42 111.10 |
Dosulepin Impurity E | N/A | C19H21NS | 295.45 |
Duloxetine-d3 HCl | 116539-59-4(non-d) | C18H16NOSD3.HCl | 300.44 36.46 |
Duloxetine Impurity B | N/A | C8H13NOS | 171.26 |
Dithizone | 60-10-6 | C13H12N4S | 256.33 |
Duloxetine Related Compound H | 199191-66-7 | C22H23NO4S | 397.5 |
Duloxetine-d7 Maleate | C18H12NOSD7 . C4H4O4 | 304.46 116.07 | |
4-Hydroxy Duloxetine-d6 | C18H13NO2SD6 | 319.46 | |
(S)-Duloxetine Phtalamide | 199191-67-8 | C26H23NO4S | 445.54 |
Duloxetine impurity (N-formyl) | C19H19NO2S | 325.43 | |
Duloxetine impurity (N-acetyl) | C20H21NO2S | 339.46 | |
Duloxetine impurity (alpha-hydroxy) | 940291-11-2 | C18H19NOS | 297.42 |
5-Hydroxy-6-Methoxy Duloxetine Sulfate-D3 | C19H18NO6S2D3 | 426.53 | |
4-Hydroxy Duloxetine-d6 beta-D-Glucuronide | C24H21NO8SD6 | 495.58 | |
4-Hydroxy duloxetine glucuronide | NULL | C24H27NO8S | 489.55 |
bis(2,4-Dichlorophenoxy)acetic Acid | 100541-30-8 | C14H8Cl4O4 | 382.03 |
5-Hydroxy-6-methoxy duloxetine sulfate | NULL | C19H21NO6S2 | 423.51 |
Desoximetasone | 382-67-2 | C22H29FO4 | 376.47 |
Desoximetasone-d6 | N/A | C22H23FO4D6 | 382.51 |
Desoximetasone Impurity E | N/A | C22H28O4 | 356.47 |
Desoximetasone Impurity G | N/A | C24H31FO5 | 418.51 |
Desoximetasone Impurity A | 61618-63-1 | C21H25FO4 | 360.43 |
Desoximetasone Impurity C | N/A | C21H24O4 | 340.42 |
Desoximetasone Impurity D | 24916-90-3 | C22H28O5 | 372.47 |
Desoximetasone Impurity F | N/A | C22H29FO3 | 360.47 |
Desoximetasone Impurity H | N/A | C24H30O5 | 356.5 |
Desoximetasone Impurity 1 (Beta Methyl 1,2-Dihydro) | C22H30O4 | 358.48 | |
Desoximetasone Impurity 2 (Beta Methyl Triene) | C22H28O4 | 356.47 | |
Desoximetasone Impurity 3 (Beta Methyl Epoxide 21-Acetate) | C24H30O6 | 414.5 | |
Desoximetasone Impurity 4 | C22H28O4 | 356.47 | |
Duloxetine HCl | C18H19NOS.HCl | 297.42 36.46 | |
n-Decyl Alcohol (1-Decanol) | 112-30-1 | C10H22O | 158.29 |
Duloxetine Impurity HBr | 949096-01-9 | C18H19NOS.HBr | 297.42 80.91 |
DIMBOA (2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one) | 15893-52-4 | C9H9NO5 | 211.18 |
3-Acetyl Duloxetine HCl (Duloxetine Related Compound F) | 1104890-90-5 | C18H19NOS.HCl | 297.42 36.46 |
DBTA (Di-O,O̢۪-benzoyl-D-(+)tartaric Acid Monohydrate) | 80822-15-7 | C18H14O8.H2O | 358.31 18.02 |
4-Hydroxy Duloxetine Acetate | C18H19NO2S.C2H4O2 | 313.42 60.05 | |
Duocarmycin (CD-1) | C35H30ClN5O4S2 | 684.24 | |
Duloxetine Impurity A | 947686-09-1 | C25H23NO3S | 417.53 |
Deoxynivalenol | 51481-10-8 | C15H20O6 | 296.32 |
Duloxetine Impurity VI | C18H19NOS | 297.42 | |
(4Z)-3-Methyl-4-undecene | 74645-87-7 | C12H24 | 168.33 |
(5E)-5-Tetradecene | 41446-66-6 | C14H28 | 196.38 |
Drospirenone | 67392-87-4 | C24H30O3 | 366.49 |
5-Beta-Hydroxy-Drospirenone Lactol | N/A | C24H34O4 | 386.54 |
3-Beta-5-Beta-Dihydroxy-Drospirenone Lactol (Mixture of Diastereomers) | N/A | C24H36O4 | 388.55 |
3-Beta-Hydroxy-Drospirenone Lactol | N/A | C24H34O3 | 370.54 |
5-Beta-Hydroxy-Drospirenone-17-Propanol | 1357252-81-3 | C24H36O4 | 388.55 |
Drospirenone Diol Impurity | N/A | C24H34O3 | 370.54 |
Drospirenone Ether Impurity | N/A | C24H32O2 | 352.52 |
Drospirenone acid sodium salt | C24H31O4.Na | 383.51 22.99 | |
Drospirenone-d4 | C24H26O3D4 | 370.53 | |
4,5-Dihydrodrospirenone-3-sulfate | C24H34O5S | 434.6 | |
4,5-Dihydrodrospirenone | C24H34O3 | 370.54 | |
Drospirenone Isomer | C24H30O3 | 366.5 | |
Drospirenone Impurity F | N/A | C24H32O3 | 368.52 |
Drospirenone Impurity (Drospirenone Lactol) | 863329-71-9 | C24H32O3 | 368.52 |
5-Beta-Hydroxy-Drospirenone Lactone | N/A | C24H32O4 | 384.52 |
Donepezil-d4 HCl | 120014-06-4 (non-d) | C24H25NO3D4.HCl | 383.53 36.46 |
6-O-Desmethyl Donepezil Glucuronide (Mixture of Diastereomers) | 220170-73-0 | C29H35NO9 | 541.6 |
Donepezil Pyridine Analog Impurity | 4803-57-0 | C17H17NO3 | 283.33 |
Donepezil Benzyl Bromide Impurity | 844694-85-5 | C31H36NO3. Br | 470.64 79.90 |
Donepezil Dehydrodeoxy Impurity | 130927-68-3 | C24H29NO2.HCl | 363.50 36.47 |
Donepezil Deoxy Impurity | 1034439-57-0 | C24H31NO2.HCl | 365.52 36.47 |
Donepezil Impurity-VI | 120012-04-6 | C24H31NO3 | 381.52 |
Donepezil open ring impurity | C24H29NO5 | 411.5 | |
Donepezil N-Oxide | C24H29NO4 | 395.5 | |
4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic Acid | 152628-03-0 | C12H14N2O2 | 218.26 |
Donepezil | 120014-06-4 | C24H29NO3 | 379.5 |
Hydroxy Donepezil | C24H29NO4 | 395.5 | |
Donepezil related compound (E/Z mixture) | 120014-07-5 | C24H27NO3 | 377.49 |
Donepezil related compound A | 145546-80-1 | C24H27NO3 | 377.49 |
Donepezil-d5 | C24H24NO3D5 | 384.53 | |
5-O-Desmethyl Donepezil | 120013-57-2 | C23H27NO3 | 365.48 |
5-O-Desmethyl Donepezil-d5 | 120013-57-2(non-d) | C23H22NO3D5 | 370.56 |
6-O-Desmethyl Donepezil | 120013-56-1 | C23H27NO3 | 365.48 |
6-O-Desmethyl Donepezil-d5 | 120013-56-1(non-d) | C23H22NO3D5 | 370.56 |
Donepezil Desbenzyl Impurity | 120013-39-0 | C17H23NO3.HCl | 289.38 36.5 |
5,6-Dimethoxy-1-Indanone (Donepezil Impurity) | C11H12O3 | 192.22 | |
Doxazosin-d8 HCl | 74191-85-8 (non-d) | C23H17N5O5D8.HCl | 459.53 36.46 |
R-Doxazosin | 70918-17-1 | C23H25N5O5 | 451.49 |
S-Doxazosin | 104874-86-4 | C23H25N5O5 | 451.49 |
Doxazosin-d8 | C23H17N5O5D8 | 459.53 | |
Doxazosin Mesylate Impurity G | N/A | C14H19N5O2 | 289.34 |
Doxepin-d3 HCl | 347840-07-7 (non-d) | C19H18NOD3.HCl | 282.40 36.46 |
N-Desmethyl Doxepin HCl | 2887-91-4 | C18H19NO HCl | 265.36 36.46 |
N-Desmethyl Doxepin-d3 HCl | N/A | C18H16NOD3 HCl | 268.38 36.46 |
Doxepin related compound A | 4504-87-4 | C14H10O2 | 210.23 |
Doxepin related compound B | 4504-88-5 | C19H23NO2 | 297.39 |
Doxepin related compound C | 4504-96-5 | C18H19NO . HCl | 265.36 36.46 |
(E)-Doxepin | 3607-34-9 | C19H21NO | 279.39 |
(Z)-Doxepin | 3607-18-9 | C19H21NO | 279.39 |
3-Ketodesogestrel (Etonogestrel) | 54048-10-1 | C22H28O2 | 324.47 |
Desogestrel delta-3 isomer | 201360-82-9 | C22H30O | 310.48 |
Desogestrel EP Impurity B | 54024-12-3 | C21H28O | 296.46 |
Desogestrel EP Impurity C | 54024-21-4 | C20H28O | 284.45 |
17-β-Desogestrel | C22H30O | 310.48 | |
Desogestrel Related Compound (3-alpha-Hydroxy Desogestrel) | 70805-84-4 | C22H30O2 | 326.48 |
3-Keto-desogestrel-D2-13C2 | C22H26D2O2 | 328.46 | |
Desogestrel Related Compound B (3-beta-Hydroxy Desogestrel) | 70805-85-5 | C22H30O2 | 326.48 |
3-Keto-desogestrel-d6 (Etonogestrel-d6) | C22H22O2D6 | 330.5 | |
3-Ketodesogestrel Sulfate (Etonogestrel sulfate) | C22H28O5S | 404.53 | |
3-Ketodesogestrel-17-O-Glucuronide | C28H36O8 | 500.59 | |
Desogestrel | C22H30O | 310.48 | |
Desogestrel-13C2-d2 | C22H28OD2 | 314.47 | |
Desogestrel Impurity | N/A | C22H30O | 310.48 |
Darifenacin | 133099-04-4 | C28H30N2O2 | 426.55 |
Darifenacin Dimer-1 | C38H40N2O3 | 572.75 | |
Darifenacin Dimer-2 | C38H40N2O3 | 572.75 | |
Darifenacin Carboxylic Acid Impurity | N/A | C27H28N2O4 | 444.54 |
Darifenacin Impurity E | C38H40N2O3 | 572.75 | |
Darifenacin Impurity H | C47H50N4O3 | 718.95 | |
Darifenacin Impurity (UK-201705) | 1048979-09-4 | C28H30N2O2 | 426.56 |
Darifenacin-d4 | 133099-04-4 (non-d) | C28H26N2O2D4 | 430.59 |
Darifenacin-d4 HBr | C28H26N2O2D4.HBr | 430.59 80.91 | |
UK-148993, 3-Hydroxy Darifenacin (Mixture of Diastereomers) | 1285875-62-8 | C28H30N2O3 | 442.56 |
Darifenacin Impurity (UK-156961) | 215032-24-9 | C28H32N2O3 | 444.58 |
Darifenacin HBr | 133099-07-7 | C28H30N2O2.HBr | 426.56 80.91 |
Darifenacin Amide Impurity | C18H20N2O | 280.37 | |
Darifenacin R-Isomer Impurity | C28H30N2O2 . HBr | 426.56 80.91 | |
Darifenacin Oxidized Impurity | 133033-99-5 | C28H28N2O2 | 424.55 |
Doxycycline-13C-d3 | 17086-28-1 (non-d) | C22H21N2O8D3 | 448.45 |
Doxycycline Monohydrate | C22H24N2O8.H2O | 444.45 18.02 | |
Doxycycline HCl | 10592-13-9 | C22H24N2O8.HCl | 444.45 36.46 |
4epi-6epi Doxycycline | 97583-08-9 | C22H24N2O8 | 444.45 |
4-epi-Doxycycline | N/A | C22H24N2O8 | 444.45 |
6-Epi Doxycycline | 3219-99-6 | C22H24N2O8 | 444.45 |
Doxycycline Hyclate Impurity F | 122861-53-4 | C23H25NO8 | 443.46 |
Docetaxel | 114977-28-5 | C43H53NO14 | 807.9 |
Docetaxel Impurity E (10-Deacetyl Baccatin III) | 32981-86-5 | C29H36O10 | 544.6 |
7-Methyl-10-(2-Hydroxy-3-N-Boc-3-Phenylpropionyl)-Docetaxel | N/A | C58H72N2O18 | 1085.22 |
7-Methyl Docetaxel | 1420767-25-4 | C44H55NO14 | 821.93 |
2-Epi Docetaxel Impurity | 133577-33-0 | C43H53NO14 | 807.9 |
Docetaxel Metabolite M1 and M3 | C43H51NO15 | 821.88 | |
Docetaxel Metabolite M2 | C43H53NO15 | 823.9 | |
Docetaxel Metabolite M4 | C43H49NO15 | 819.87 | |
Docetaxel Metabolite M2-d6 | C43H47NO15D6 | 829.94 | |
Docetaxel Metabolite M4-d6 | C43H43NO15D6 | 825.9 | |
Docetaxel-d9 | 114977-28-5 (non-d) | C43H44NO14D9 | 816.95 |
Docetaxel Impurity C (7-Epi-Docetaxel) | C43H53NO14 | 807.9 | |
Docetaxel Impurity D (7-Epi-10-Oxo-Docetaxel) | C43H51NO14 | 805.88 | |
10-Acetyl Docetaxel | 125354-16-7 | C45H55NO15 | 849.94 |
2-Debenzoyl-2-pentenoyl Docetaxel | N/A | C41H55NO14 | 785.89 |
6-Oxo-Docetaxel | C43H51NO15 | 821.88 | |
Docetaxel Impurity A | C41H55NO14 | 785.89 | |
Docetaxel Impurity B (10-Oxo Docetaxel) | 167074-97-7 | C43H51NO14 | 805.88 |
Dapoxetine HCl | 129938-20-1 | C21H23NO.HCl | 305.42 36.46 |
Dapoxetine Impurity 2 | C30H31NO2 | 437.59 | |
Dapoxetine Impurity 3 | C11H17N | 163.26 | |
Dapoxetine Impurity 4 | C21H23NO | 305.42 | |
R- Dapoxetine | C21H23NO | 305.42 | |
N-Desmethyl Dapoxetine HCl | C20H14NOD7.HCl | 298.44 36.46 | |
N-Didesmethyl Dapoxetine | C19H19NO | 277.37 | |
Dapoxetine-d7 HCl | 119356-77-3 (non-d) | C21H16NOD7.HCl | 312.47 36.46 |
N-Desmethyl Dapoxetine-d7 HCl | C20H14NOD7.HCl | 298.44 36.46 | |
Dapoxetine 2-Naphthyl Impurity | N/A | C29H29NO2 HCl | 423.56 |
Dapoxetine 4-Phenylethylene Impurity HCl | N/A | C29H29NO. HCl | 407.56 36.46 |
Dapoxetine (free base) | 119356-77-3 | C21H23NO | 305.42 |
Dapoxetine Impurity 1 | N/A | C19H16O | 260.34 |
DAIDZEIN | DAIDZEIN | 258.27 | |
Didanosine-d2 | C10H12N4O3D2 | 240.26 | |
Diflufenican-d3 | C19H8F5N2O2D3 | 397.32 | |
Dipyridamole | 58-32-2 | C24H40N8O4 | 504.64 |
Dipyridamole Impurity F | C21H36N8O5 | 480.57 | |
Dipyridamole Impurity G | 08-02-7139 | C16H20Cl2N6 | 367.28 |
Dipyridamole Impurity 1 | N/A | C19H31N7O5 | 437.5 |
Dipyridamole Impurity 2 | N/A | C24H40N8O5 | 520.64 |
Dipyridamole-d20 | 58-32-2 (non-d) | C24H20N8O4D20 | 524.76 |
Dipyridamole-d16 | C24H24N8O4D16 | 520.73 | |
Dipyridamole Impurity I | C28H44N8O9 | 636.71 | |
Dipyridamole Impurity A | 16982-40-4 | C25H40N8O2 | 484.65 |
Dipyridamole Impurity B | 16908-47-7 | C23H40N8O6 | 524.63 |
Dipyridamole Impurity C | 54093-92-4 | C20H30ClN7O2 | 435.96 |
Dipyridamole Impurity D | 1176886-12-6 | C22H36N8O3 | 460.58 |
Dipyridamole Impurity E | C24H40N8O4 | 504.64 | |
Deferasirox | 201530-41-8 | C21H15N3O4 | 373.37 |
Deferasirox Acyl beta-D-Glucuronide | 1233196-91-2 | C27H23N3O10 | 549.5 |
Deferasirox-d4 | 201530-41-8 (non-d) | C21H11N3O4D4 | 377.4 |
Deferasirox Iron Complex | C42H26FeN6O8 | 798.56 | |
Deferasirox Impurity 1 | C28H19N3O6 | 493.48 | |
Deferasirox Impurity 2 | C23H17N3O6 | 431.41 | |
Deferasirox Ethyl Ester | 201530-79-2 | C23H19N3O4 | 401.43 |
Deferasirox Methyl Ester | 1266741-05-2 | C22H18N3O4 | 388.41 |
Deferasirox Iron Complex-d8 | 554445-58-8 (non-labelled) | C42H16FeN6O8D8. K3 | 804.59 3 39.10 |
Deferasirox impurity G | C21H15N3O3 | 357.37 | |
Docosahexaenoic acid (DHA) | 6217-54-5 | C22H32O2 | 328.5 |
Docosahexaenoic acid (DHA)-d5 | 6217-54-5 (non-d) | C22H27O2D5 | 333.53 |
Docosahexaenoic Acid Ethyl Ester-d5 | C24H31O2D5 | 361.58 | |
Docosahexaenoic Acid Ethyl Ester | C24H36O2 | 356.55 | |
Dantrolene-d4 | C14H6N4O5D4 | 318.28 | |
5-Hydroxy Dantrolene-d4 | C14H6N4O6D4 | 334.28 | |
5-Hydroxy Dantrolene | C14H10N4O6 | 330.26 | |
Diazald | 80-11-5 | C8H10N2O3S | 214.24 |
Dexanabinol | 112924-45-5 | C25H38O3 | 386.58 |
Dasatinib | 302962-49-8 | C22H26ClN7O2S | 488.02 |
Dasatinib Impurity 5 | C24H28ClN7O3S | 530.05 | |
Dasatinib Impurity 6 | C22H25Cl2N7O2S | 522.46 | |
Dasatinib Impurity 7 | C22H25Cl2N7O2S | 522.46 | |
Dasatinib Impurity 8 | C36H34Cl2N12O2S2 | 801.79 | |
N-Deshydroxyethyl Dasatinib-d8 | N/A | C20H14ClN7OSD8 | 452.01 |
4̢۪-Hydroxy Dasatinib | 910297-57-3 | C22H26ClN7O3S | 504.01 |
2-Deschloro-2-hydroxy Dasatinib | 1159977-25-9 | C22H27N7O3S | 469.57 |
Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib | 910297-71-1 | C16H13Cl2N5O2S | 410.28 |
Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro-O-pivalate Dasatinib | 910297-70-0 | C21H21Cl2N5O3S | 494.4 |
Hydroxymethyl Dasatinib | 910297-58-4 | C22H26ClN7O3S | 504.01 |
Dasatinib-d8 | 302962-49-8 (non-d) | C22H18ClN7O2SD8 | 496.06 |
Dasatinib Carboxylic Acid | 910297-53-9 | C22H24ClN7O3S | 502 |
Dasatinib N-Oxide | C22H26ClN7O3S | 504.01 | |
Dasatinib Glucuronide | C28H34ClN7O8S | 664.14 | |
N-Deshydroxy Ethyl Dasatinib | C20H22ClN7OS | 443.96 | |
Dasatinib Impurity 1 | C22H25Cl2N7O2S | 522.46 | |
Dasatinib Impurity 2 | 302964-24-5 | C11H10ClN3OS | 267.74 |
Dasatinib Impurity 3 | C16H13Cl2N5OS | 394.28 | |
Dasatinib Impurity 4 | C22H27N7O2S | 453.57 | |
Deflazacort | C25H31NO6 | 441.53 | |
21-Hydroxy Deflazacort (21-Desacetyl Deflazacort) | C23H29NO5 | 399.49 | |
Levodopa Impurity D (3,4-Dihydroxy-D-Phenylalanine) | 5796-17-8 | C9H11NO4 | 197.19 |
3-O-methyl dopa sulfate | C9H13NO5S | 247.27 | |
Dopamine HCl | 62-31-7 | C8H11NO2.HCl | 153.18 36.46 |
4-O-Methyldopa | C10H13NO4 | 211.22 | |
4-O-Methyldopa-d3 | C10H10NO4D3 | 214.24 | |
Levodopa | C9H11NO4 | 197.19 | |
6-Hydroxy Dopamine-d4 | N/A | C8H7NO3D4 | 173.21 |
6-Hydroxy-L-DOPA (Levodopa Related Compound A) | 27244-64-0 | C9H11NO5 | 213.19 |
3-(3,4-Dimethoxyphenyl)-L-alanine | 32161-30-1 | C11H15NO4 | 225.25 |
3-Methoxytyramine | 554-52-9 | C9H13NO2 | 167.21 |
(DL)-3-O-Methyldopa (Levodopa Related Compound B) | 4214-13-5 | C10H13NO4 | 211.22 |
3-O-Methyldopa | 7636-26-2 | C10H13NO4 | 211.22 |
Carbidopa Related Compound A | 85933-19-3 | C11H16N2O4 | 240.26 |
Methyldopa-d3 | C10H10NO4D3 | 214.24 | |
Dopamine-d4 HCl | C8H7NO2D4 . HCl | 157.21 36.46 | |
Methyldopa Impurity A | 6739-31-7 | C11H15NO4 | 225.25 |
Levodopa-d3 | 53587-29-4 | C9H8NO4D3 | 200.21 |
Carbidopa-d3 | 28860-95-9 (non-d) | C10H11N2O4D3 | 229.25 |
Levodopa sulfate | C9H11NO7S | 277.25 | |
3-O-methyl dopa glucuronide | C16H21NO10 | 387.35 | |
3-O-methyldopa-d3 | C10H10NO4D3 | 214.24 | |
Disulfiram | 97-77-8 | C10H20N2S4 | 296.54 |
Disulfiram-d20 | 97-77-8 (non-d) | C10N2S4D20 | 316.65 |
S-Methyl N, N-Diethyldithiocarbamate | 686-07-7 | C6H13NS2 | 163.31 |
S-Methyl N, N-Diethyldithiocarbamate-d10 | 686-07-7 (non-d) | C6H3NS2D10 | 173.42 |
Diethyldithiocarbamate | C5H10NNaS2 . 3 H2O | 171.26 3 18.02 | |
Doxorubicin HCl | 25316-40-9 | C27H29NO11. HCl | 543.53 36.46 |
Desmethyl doxorubicin (14-Hydroxycarminomycin) | 69401-50-9 | C26H27NO11 | 529.51 |
Doxorubicin impurity C | C27H28BrNO10 | 606.43 | |
Doxorubicin Impurity 3 | C20H12O7 | 364.31 | |
Doxorubicin Impurity 4 | C26H25NO10 | 511.49 | |
Doxorubicin Dimer Impurity 1 | C54H56N2O21 | 1069.05 | |
Doxorubicin Dimer Impurity 2 | C44H46N2O16 | 858.86 | |
Doxorubicin-13C-d3 | 23214-92-8 (non-d) | C27H26NO11D3 | 547.56 |
Doxorubicinol (mixture of diasteromers) | 63950-05-0 | C27H31NO11 | 545.55 |
Doxorubicinol-13C-d3 (mixture of diasteromers) | 63950-05-0 (non-d) | C27H28NO11D3 | 549.58 |
Epi-doxorubicin | 56420-45-2 | C27H31NO11 | 545.55 |
Doxorubicinone | 24385-10-2 | C21H18O9 | 414.37 |
Doxorubicin Impurity 1 | C19H12O7 | 352.3 | |
Doxorubicin Impurity 2 | 64845-67-6 | C19H12O6 | 336.3 |
Doxorubicin Impurity B | 106401-68-7 | C29H34BrNO11 | 652.5 |
Dutasteride | C27H30F6N2O2 | 528.54 | |
Dutasteride Impurity D (Dutasteride 17-alfa-5-ene) | C27H28F6N2O2 | 526.53 | |
Dutasteride Impurity | C26H22F6N2O2 | 508.47 | |
Dutasteride Impurity A (Dutasteride Acid Impurity) | N/A | C19H27NO3 | 317.43 |
Dutasteride Ester Impurity | C20H29NO3 | 331.46 | |
Dutasteride Impurity G (Dutasteride 17-beta-5-ene) | 1430804-85-5 | C27H28F6N2O2 | 526.53 |
Dutasteride Impurity B | C21H32N2O2 | 344.5 | |
Dutasteride Impurity C | 157307-36-3 | C21H31NO3 | 345.49 |
Dutasteride Impurity | N/A | C27H26F6N2O2 | 524.51 |
Dutasteride Impurity J | 164656-21-7 | C27H30F6N2O2 | 528.54 |
Dutasteride Impurity L | 1365545-48-7 | C26H26F6N2O2 | 512.5 |
Dutasteride-13C6 | C21H30F6N2O213C6 | 534.48 | |
Dutasteride Impurity M | N/A | C18H24N2O2 | 300.4 |
Dutasteride Impurity F (1-Chloro Dihydro Dutasteride) | 1365545-42-1 | C27H31ClF6N2O2 | 565 |
Dihydro Dutasteride | 164656-22-8 | C27H32F6N2O2 | 530.56 |
5-Beta-Dutasteride | 957229-52-6 | C27H30F6N2O2 | 528.54 |
6-Beta-Hydroxy Dutasteride | N/A | C27H32F6N2O3 | 546.56 |
Dutasteride Impurity H (alfa-Dimer) | N/A | C46H55F6N3O4 | 827.96 |
Dutasteride Impurity I (beta-Dimer) | N/A | C46H55F6N3O4 | 827.96 |
Dutasteride Impurity E (Dutasteride 17-alfa-epimer) | C27H30F6N2O2 | 528.54 | |
Dexamethasone-d4 | 50-02-2 (non-d) | C22H25FO5D4 | 396.5 |
Dexamethasone Sodium phosphate Impurity G ((-)-Dexamethasone Acid) | 37927-01-8 | C21H27FO5 | 378.44 |
21-Hemiacetal Dexamethasone | 473273-03-9 | C23H31FO6 | 422.5 |
Dexamethasone Impurity F | N/A | C22H29FO4 | 376.47 |
Dexamethasone Impurity I | N/A | C22H28O5 | 372.47 |
Dexamethasone Impurity J | 2036-77-3 | C22H28O5 | 372.47 |
Dexamethasone Impurity K | N/A | C22H26O4 | 354.45 |
Dexamethasone-17(20)-enol-21-aldehyde | 6762-51-2 | C22H27FO4 | 374.46 |
Dexamethasone-17-ketone | 1880-61-1 | C20H25FO3 | 332.42 |
6-Hydroxy Dexamethasone | C22H29FO6 | 408.47 | |
Dexamethasone 17-formyloxy17-acid | C22H27FO6 | 406.46 | |
Dexamethasone Biotin | 85679-56-7 | C36H53FN4O6S | 688.91 |
Dexamethasone Phosphate Impurity | N/A | C22H30FO11PS 2 Na | 552.51 2x22.99 |
Dexamethasone | 50-02-2 | C22H29FO5 | 392.47 |
17-Beta-Carboxy-17-Desoxy-Dexamethasone | 75262-69-0 | C21H27FO4 | 362.45 |
21-Dehydro-17-Deoxy-Dexamethasone | 1188271-71-7 | C22H27FO4 | 374.46 |
Dexamethasone Impurity I (21-Dehydro Dexamethasone) | 2964-79-6 | C22H27FO5 | 390.46 |
Dexamethasone Impurity C | 426-17-5 | C22H31FO5 | 394.49 |
Dexamethasone Acid Impurity | 75262-69-0 | C21H27FO4 | 362.45 |
Dexamethasone Sodium phosphate Impurity C, D, E, F | N/A | C22H30FO8P | 472.45 |
Darunavir | 206361-99-1 | C27H37N3O7S | 547.68 |
Darunavir Ethanolate | 635728-49-3 | C27H37N3O7S C26O | 547.68 46.07 |
BIS THF HNS Derivative 1 | 253265-98-4 | C11H13NO7 | 271.23 |
BIS THF HNS Derivative 2 | 799241-85-3 | C11H13NO7 | 271.23 |
BIS THF HNS Derivative 3 | 799241-86-4 | C11H13NO7 | 271.23 |
BIS THF Nitro Derivative 1 | 288296-64-0 | C13H13NO7 | 295.25 |
BIS THF Nitro Derivative 2 | 252873-01-1 | C13H13NO7 | 295.25 |
BIS THF Nitro Derivative 3 | 252873-00-0 | C13H13NO7 | 295.25 |
DNV-II impurity 1 | 1005324-46-8 | C25H35N3O7S | 521.64 |
DNV-II impurity 2 | 1133153-38-4 | C25H35N3O7S | 521.64 |
Darunavir-d9 | 206361-99-1 (non-d) | C27H28N3O7SD9 | 556.73 |
Hydroxy Darunavir | 1130635-75-4 | C27H37N3O8S | 563.68 |
3̢۪-Hydroxy Darunavir | 1159613-24-7 | C27H37N3O8S | 563.68 |
Darunavir-N-Glucuronide | 1159613-25-8 | C33H45N3O13S | 723.8 |
Darunavir-O-Glucuronide | 1159613-27-0 | C33H45N3O13S | 723.8 |
Darunavir Related Compound 03 | N/A | C34H45N3O11S | 703.82 |
Darunavir Related Compound 04 | N/A | C27H37N3O7S | 547.68 |
Darunavir Monohydroxylated Carbamate hydrolyzed metabolite (R426855) | C20H29N3O4S | 407.54 | |
Doxylamine-d5 Succinate | C17H17N2OD5.C4H6O4 | 275.41 118.09 | |
N,N-Didesmethyl Doxylamine | C16H19NO | 241.34 | |
Doxylamine Impurity B | 19490-92-7 | C13H13NO | 199.25 |
Desmethyl Doxylamine Succinate | 1221-70-1 (free base) | C16H20N2O. C4H6O4 | 256.35 118.09 |
R-Doxylamine | C17H22N2O | 270.38 | |
S-Doxylamine | C17H22N2O | 270.38 | |
Doxylamine Pyridine N-oxide | C18H24N2O2 | 300.4 | |
Doxylamine Aliphatic N-Oxide HCl | C17H22N2O2.HCl | 286.38 36.46 | |
Doxylamine Pyridine N-Oxide HCl | C17H22N2O2.HCl | 286.38 36.46 | |
Doxylamine | 469-21-6 | C17H22N2O | 270.38 |
Doxylamine Impurity A HCl | 873407-01-3 (free base) | C17H22N2O. HCl | 270.38 36.46 |
Doxylamine di-N-Oxide | C17H22N2O3 | 302.38 | |
Doxylamine Succinate | 562-10-7 | C17H22N2O. C4H6O4 | 270.38 118.09 |
N-Monodesmethyl Doxylamine | C17H21NO | 255.36 | |
Doramectin | C50H74O14 | 899.14 | |
Dexpanthenol (Pantothenyl Alcohol) | C9H19NO4 | 205.26 | |
Dexpanthenol impurity B | 1112-33-0 | C6H12O4 | 148.16 |
Dexpanthenol impurity C | 1112-32-9 | C6H12O4 | 148.16 |
Dexpanthenol impurity D | 13031-04-4 | C6H8O3 | 128.13 |
Dexpanthenol impurity E | 96305-22-5 | C9H14O3 | 170.21 |
Dexpanthenol impurity F | 124402-18-2 | C9H16O3 | 172.23 |
Dexpanthenol impurity I | 18679-90-8 | C10H19NO5 | 233.27 |
Dexpanthenol impurity J | 49831-65-4 | C10H19NO5 | 233.27 |
Desonide | C24H32O6 | 416.52 | |
Delta-14-Desonide | 131918-67-7 | C24H30O6 | 414.5 |
Desonide 1,2-Saturated | 638-93-7 | C24H34O6 | 418.53 |
Desonide Delta-9(11) analog | 5541-37-7 | C24H30O5 | 398.5 |
Dienogest | C20H25NO2 | 311.43 | |
Dienogest Impurity B | N/A | C18H22O2 | 270.37 |
Dienogest Impurity D | N/A | C22H29NO3 | 355.48 |
Dienogest Impurity E | N/A | C22H31NO3 | 357.5 |
Dienogest Impurity F | N/A | C20H27NO2 | 313.44 |
Dienogest Impurity G | N/A | C20H23NO2 | 309.41 |
Dienogest Impurity H | N/A | C20H25NO2 | 311.43 |
Dienogest Impurity I | N/A | C20H27NO2 | 313.44 |
Dienogest Impurity J | N/A | C21H27NO2 | 325.45 |
Dienogest Impurity K | N/A | C21H27NO3 | 341.45 |
Dienogest Impurity L | N/A | C20H26O3 | 314.43 |
Dienogest-d5 | C20H20NO2D5 | 316.46 | |
Dienogest Impurity M | N/A | C20H24BrNO2 | 390.32 |
Dienogest Impurity 1 | 510-64-5 | C19H26O3 | 302.42 |
Dienogest Impurity 2 | 734-32-7 | C18H24O2 | 272.39 |
11beta-hydroperoxy Dienogest | NA | C20H25NO4 | 343.43 |
11beta-hydroxy Dienogest | NA | C20H25NO3 | 327.43 |
Dienogest-d4 | C20H21NO2D4 | 315.45 | |
Dienogest Impurity C (Diene Impurity) | 106111-42-6 | C20H25NO2 | 311.43 |
6-beta-Hydroxy Dienogest | C20H25NO3 | 327.43 | |
17-epi-Dienogest | N/A | C20H25NO2 | 311.43 |
Dienogest Impurity A | N/A | C20H25NO3 | 327.43 |
Diazoxide | C8H7ClN2O2S | 230.67 | |
Diazoxide-d3 | C8H4ClN2O2SD3 | 233.69 | |
5,7-Dichloro-3-Methyl-2H-1,2,4-Benzothiadiazine-1,1-Dioxide | 6059-27-4 | C8H6Cl2N2O2S | 265.12 |
7,8-Dichloro-3-Methyl-2H-1,2,4-Benzothiadiazine-1,1-Dioxide | 31365-86-3 | C8H6Cl2N2O2S | 265.12 |
Dropropizine | 17692-31-8 | C13H20N2O2 | 236.32 |
Levodropropizine (S-Dropropizine) | 99291-25-5 | C13H20N2O2 | 236.32 |
6-Iodo Diosmin | C28H31IO15 | 734.45 | |
Diosmin-d3 | C28H29O15D3 | 611.58 | |
Diosmin | 520-27-4 | C28H32O15 | 608.56 |
Diosmin Impurityu C (Isorhoifolin) | 552-57-8 | C27H30O14 | 578.53 |
Diosmin Impurity E (Linarin) | 480-36-4 | C28H32O14 | 592.56 |
Digitoxin | C41H64O13 | 764.96 | |
Diosmetin | 520-34-3 | C16H12O6 | 300.27 |
Diosmetin-d3 | 1189728-54-8 | C16H9O6D3 | 303.29 |
Diosmetin- Beta-D-glucuronide | C23H21O11 . Na | 473.42 22.99 | |
Daunorubicin HCl | C27H29NO10.HCl | 527.53 36.46 | |
Daunorubicinol (mixture of diastereomers) (Daunorubicin Impurity B) | N/A | C27H31NO10 | 529.55 |
8-Desacetyl-8-Carboxy Daunorubicin Hydrochloride | 58199-96-5 | C26H27NO11 HCl | 529.51 36.46 |
Daunorubicin Impurity C (Mixture of Diastereomers) | N/A | C28H31NO10 | 541.56 |
Daunorubicin Impurity E (Mixture of Diastereomers) | N/A | C21H20O8 | 400.39 |
Daunorubicin Impurity F (Mixture of Diastereomers) | N/A | C28H31NO10 | 541.56 |
Domperidone | 57808-66-9 | C22H24ClN5O2 | 425.92 |
1,3-Dihydro-2H-benzimidazol-2-one | 615-16-7 | C7H6N2O | 134.14 |
Domperidone-d6 | 1329614-18-7 | C22H18ClN5O2D6 | 431.96 |
Domperidone Impurity A | C12H14ClN3O | 251.72 | |
Domperidone Impurity B | C13H14ClN3O2 | 279.73 | |
Domperidone Impurity C | 118435-03-3 | C22H24ClN5O3 | 441.92 |
Domperidone Impurity D | C32H34ClN7O3 | 600.13 | |
Domperidone Impurity E | 1346602-50-3 | C32H34ClN7O3 | 600.13 |
Domperidone Impurity F | N/A | C37H42Cl2N8O3 | 717.71 |
Domperidone Impurity | 62780-89-6 | C10H11ClN2O | 210.66 |
Deferiprone | 30652-11-0 | C7H9NO2 | 139.16 |
Deferiprone-d3 | 1346601-82-8 | C7H6NO2D3 | 142.17 |
Deferiprone 3-Glucuronide | 141675-48-1 | C13H17NO8 | 315.28 |
Deferiprone-d3 3-Glucuronide | C13H14NO8D3 | 318.3 | |
Dronedarone | 141626-36-0 | C31H44N2O5S | 556.77 |
Dronedarone Hydrochloride Impurity B | C32H46N2O7S2 | 634.86 | |
Dronedarone Hydrochloride Impurity C | C19H17NO5 | 339.35 | |
Dronedarone Hydrochloride Impurity D | C30H40N2O5 | 508.66 | |
Dronedarone Hydrochloride Impurity E | C20H19NO5 | 353.38 | |
Dronedarone-d9 | C31H35N2O5SD9 | 565.82 | |
Dronedarone-d6 HCl | 1329809-23-5 | C31H38N2O5SD6. HCl | 562.81 36.46 |
N-Desbutyl Dronedarone HCl | 197431-02-0 | C27H36N2O5S. HCl | 500.66 36.46 |
N-Desbutyl Dronedarone-d6 HCl | 1346598-70-6 | C27H30N2O5SD6. HCl | 506.70 36.46 |
N-Debutyl Dronedarone-D-Glucuronide | N/A | C33H44N2O11S | 676.79 |
2-(2-Formyl-4-Nitrophenoxy)-Hexanoate | 335153-23-6 | C14H17NO6 | 295.28 |
2-(2-Formyl-4-Nitrophenoxy)-Hexanoic Acid | 335153-21-4 | C13H15NO6 | 281.27 |
Dronedarone Hydrochloride Impurity A | C30H42N2O3 | 478.68 | |
Diflunisal Phenolic Glucuronide Lithium Salt | C19H14F2O9.2 Li | 424.31 2 6.94 | |
Diflunisal Acyl Glucuronide | 58446-30-3 | C19H16F2O9 | 426.33 |
Diflunisal | 22494-42-4 | C13H8F2O3 | 250.2 |
Diflunisal-d3 | 1286107-99-0 | C13H5F2O3D3 | 253.22 |
Diminazene Aceturate | 908-54-3 | C14H15N7.2 C4H7NO3 | 281.32 2 117.11 |
Diacerein-d6 | C19H6D6O8 | 374.33 | |
Monoacerein (5-Acetyl Rhein) | 875535-35-6 | C17H10O7 | 326.27 |
Domiphen Bromide | C22H40NO.Br | 334.57 79.90 | |
Difenoconazole | 119446-68-3 | C19H17Cl2N3O3 | 406.27 |
Difenoconazole Impurity 1 | 1259033-72-1 | C20H19Cl2N3O3 | 420.3 |
Difenoconazole Impurity 2 | C19H16Cl3N3O3 | C19H16Cl3N3O3 | |
Doripenem | 14816-81-3 | C15H24N4O6S2 | 420.51 |
Doripenem Impurity I | C15H26N4O7S2 | 438.53 | |
Doripenem Impurity II (Doripenem Dimer Impurity B) | C30H48N8O12S4 | 841.02 | |
Doripenem 4R Isomer Impurity | C20H28N4O9S2 | 532.6 | |
Doripenem impurity (4,7-seco-doripenem disodium salt, mixture of double bond isomers) | C15H24N4O7S2 . 2Na | 436.51 2x22.99 | |
Doripenem Impurity MAP-alfa isomer | C29H27N2O10P | 594.52 | |
Doripenem Dimer Impurity A1 | N/A | C29H46N8O13S4 | 842.99 |
Doripenem Dimer Impurity A2 | N/A | C29H46N8O13S4 | 842.99 |
Deltamethrin | C22H19Br2NO3 | 505.21 | |
Deltamethrin-d5 | N/A | C22H14Br2NO3D5 | 510.24 |
Dabigatran | 211914-51-1 | C25H25N7O3 | 471.52 |
Dabigatran impurity D | C34H41N7O5 | 627.75 | |
Dabigatran impurity E | 1610758-22-9 | C34H41N7O5 | 627.75 |
Dabigatran impurity F | C20H22N4O3 | 366.42 | |
Dabigatran impurity G | C19H20N4O4 | 368.4 | |
Dabigatran Impurity H | 1408238-36-7 | C26H33N5O4 | 479.58 |
Dabigatran impurity I | 211915-84-3 | C28H27N5O3 | 481.56 |
Dabigatran impurity J | C29H32N6O4.HCl | 528.62 36.5 | |
Dabigatran impurity K | C33H39N7O5 | 613.72 | |
Dabigatran impurity L | C32H38N8O4 | 598.71 | |
Dabigatran impurity M | C27H28N6O4 | 500.56 | |
Dabigatran-d3 | NA | C25H22N7O3D3 | 474.54 |
Dabigatran impurity O | C27H29N7O3.HCl | 499.58 | |
Dabigatran impurity P | 212322-56-0 | C18H22N4O3 | 342.4 |
Dabigatran impurity Q | C27H28N6O4 | 500.56 | |
Dabigatran Impurity I Related Compound | C33H40N6O4 | 584.72 | |
Dabigatran Etexilate Impurity 1 | C35H43N7O5 | 641.78 | |
Dabigatran Etexilate Impurity 2 | C34H41N7O5 | 627.75 | |
Dabigatran Etexilate Impurity 3 | C32H37N7O5 | 599.7 | |
Dabigatran Etexilate Impurity 4 | C35H43N7O5 | 641.78 | |
Dabigatran Etexilate Impurity 5 | C36H45N7O5 | 655.8 | |
Dabigatran etexilate | 211915-06-9 | C34H41N7O5 | 627.75 |
Desethyl Dabigatran Etexilate | 212321-78-3 | C32H37N7O5 | 599.7 |
Dabigatran Acyl-Beta-D-Glucuronide | 1015167-40-4 | C31H33N7O9 | 647.65 |
Dabigatran Etexilate N-Oxide (impurity N) | 1381757-44-3 | C34H41N7O6 | 643.75 |
Dabigatran-d3 Ethyl Ester | N/A | C27H26N7O3D3 | 502.6 |
Dabigatran-d4 | 211914-51-1 (non-labelled) | C25H21N7O3D4 | 475.55 |
Dabigatran impurity A | C32H37N7O5 | 599.7 | |
Dobutamine Impurity B | NA | C10H12O2 | 164.21 |
Dobutamine Impurity C HCl | 51062-14-7 | C21H29NO3. HCl | 343.47 36.46 |
rac-Dobutamine-d4 HCl | N/A | C18H19NO3D4 HCl | 305.41 36.46 |
rac-Dobutamine-d6 HCl | N/A | C18H17NO3D6 HCl | 307.43 36.46 |
Dapagliflozin-d5 | NA | C21H20ClO6D5 | 413.91 |
Dapagliflozin-d7 | NA | C21H18ClO6D7 | 415.93 |
Dapagliflozin | 461432-26-8 | C21H25ClO6 | 408.88 |
Dapagliflozin alfa-Isomer | N/A | C21H25ClO6 | 408.88 |
Dapagliflozin Impurity 1 | C15H12BrClO2 | 339.62 | |
Dapagliflozin Impurity 2 | C15H14BrClO | 325.64 | |
Dapagliflozin Impurity 3 | C21H25BrO6 | 453.33 | |
Dapagliflozin Impurity 4 | C21H25ClO6 | 408.88 | |
Dorzolamide | 120279-96-1 | C10H16N2O4S3 | 324.44 |
Dorzolamide Impurity D | 154154-90-2 | C8H12N2O4S3 | 296.39 |
Dorzolamide Related Compound A | C10H16N2O4S3 . HCl | 324.44 36.46 | |
Dorzolamide Related Compound B | 122028-16-4 | C10H16N2O4S3 . HCl | 324.44 36.46 |
Dorzolamide impurity C | C10H17BN2O6S3 | 368.26 | |
Dibucaine Impurity D | 10222-61-4 | C14H15NO3 | 245.28 |
Dalfampridine (4-Aminopyridine) | 504-24-5 | C5H6N2 | 94.12 |
4-Aminopyridine N-oxide | 3535-75-9 | C5H6N2O | 110.12 |
(S)-(+)-DBD-PY-NCS | 163927-32-0 | C13H15N5O3S2 | 353.42 |
Dicloxacillin | 3116-76-5 | C19H17Cl2N3O5S | 470.33 |
Dicloxacillin-13C4 | N/A | C19H17Cl2N3O5S | 474.29 |
Acetylated Penicilloic Acid | C21H21Cl2N3O7S | 530.39 | |
Degradation Impurity (DCMICAA) | C13H10Cl2N2O4 | 329.14 | |
DCMICAA Adduct of Dicloxacillin peniclloic acids | C32H27Cl4N5O9S | 799.48 | |
Dicloxacilloic Acid | C19H19Cl2N3O6S | 488.35 | |
Dicloxacillin Impurity B | C18H19Cl2N3O4S | 444.34 | |
Dicloxacillin Impurity D | 3919-76-4 | C11H7Cl2NO3 | 272.09 |
Difloxacin HCl | C21H19F2N3O3. HCl | 399.40 36.46 | |
Difloxacin Impurituy A | N/A | C26H30FN5O3 | 479.56 |
Difloxacin Impurituy C | N/A | C21H19ClFN3O3 | 415.86 |
Difloxacin Impurituy D | N/A | C21H19ClFN3O3 | 415.86 |
Difloxacin Impurituy E | N/A | C21H19ClFN3O3 | 415.86 |
Difloxacin Impurituy F | N/A | C27H23F3N4O2 | 492.51 |
Difloxacin Impurituy G | N/A | C16H8ClF2NO3 | 335.7 |
Dimefline Hydrochloride | 1165-48-6 | C20H21NO3 | 323.4 |
Dimepranol | 108-16-7 | C5H13NO | 103.17 |
Dimepranol-d6 | C5H7NOD6 | 109.2 | |
Dimepranol-N-Oxide | C5H13NO2 | 119.16 | |
Dimepranol Related Compound (N,N-Dimethylamino-2-propanol p-Acetamido benzoic acid (DiP.PAcBA)) | 61990-51-0 | C9H9NO3. C5H13NO | 179.18 103.17 |
Demeclocycline | C21H21ClN2O8 | 464.86 | |
4-epidemeclocycline | C21H21ClN2O8 | 464.86 | |
Diethylstilbestrol | C18H20O2 | 268.36 | |
Diethylstilbestrol-d5 | C18H15O2D5 | 273.39 | |
3-Hydroxy Detomidine Hydrochloride | 115664-37-4 | C12H14N2O . HCl | 202.26 36.46 |
3-Hydroxy Detomidine-15N2,d2 Hydrochloride | C12H12N2OD2 . HCl | 206.26 36.46 | |
3-Hydroxy Detomidine | C12H14N2O | 202.26 | |
3-Carboxy Detomidine | C12H12N2O2 | 216.24 | |
Detomidine HCl | 90038-01-0 | C12H14N2. HCl | 186.26 36.46 |
Digoxin | 20830-75-5 | C41H64O14 | 780.96 |
Digoxin Impurity K | N/A | C47H74O17 | 911.1 |
Digoxigenin mono-digitoside | 5352-63-6 | C29H44O8 | 520.67 |
Lanatoside C (Digoxin Impurity H) | 17575-22-3 | C49H76O20 | 985.14 |
Lanatoside B | C49H76O20 | 985.14 | |
Digoxin-d3 | 20830-75-5 (non-D) | C41H61O14D3 | 783.98 |
Digoxin Impurity B | 4562-36-1 | C41H64O14 | 780.96 |
Digoxin Impurity D | C29H44O8 | 520.67 | |
Digoxin Impurity E | 52589-12-5 | C41H64O1 | 796.96 |
Digoxin Impurity F | 02-05-5297 | C35H54O11 | 650.81 |
Digoxin Impurity G (Neodigoxin) | 55576-67-5 | C41H64O14 | 780.96 |
Digoxin Impurity I | 5511-98-8 | C43H66O15 | 823 |
Digoxin Impurity J | 5355-48-6 | C43H66O15 | 823 |
Digallic Acid | C14H10O9 | 322.23 | |
Decitabine (5-Aza-2'-deoxy Cytidine) | C8H12N4O4 | 228.21 | |
Decitabine Impurity 4 (Methyl-2-deoxy-alfa-D-Ribopyranoside) | 6160-56-1 | C6H12O4 | 148.16 |
Decitabine impurity 5 | C13H16O5 | 252.27 | |
Decitabine impurity 6 (beta-D-Erythro-Pentopyranoside-Methyl-2-Deoxy-bis(4-methylbenzoate)) | 78185-67-8 | C22H24O6 | 384.43 |
Decitabine impurity 7 | C21H21ClO5 | 388.85 | |
Decitabine impurity 8 | C8H12N4O4 | 228.21 | |
Decitabine Impurity 4 (Methyl 2-deoxy-beta-D-Ribopyranoside) | 17676-20-9 | C6H12O4 | 148.16 |
Decitabine Impurity 6 (alpha-D-Erythro-Pentopyranoside-Methyl-2-Deoxy-bis(4-methylbenzoate)) | 78185-66-7 | C22H24O6 | 384.43 |
Decitabine Impurity C | C8H12N4O4 | 228.21 | |
Decitabine Impurity B | C16H18N4O5 | 346.35 | |
Decitabine-15N4 | N/A | C8H12N4O4 | 232.18 |
Decitabine Deformyl Impurity Formate (Mixture of Diastereomers) | 570410-72-9 (free base) | C7H14N4O4. CH2O2 | 218.21 46.03 |
Decitabine impurity (ring-opening) | C8H14N4O5 | 246.22 | |
Decitabine impurity 1 | C6H12O4 | 148.16 | |
Decitabine impurity 2 | 4330-34-1 | C22H24O6 | 384.43 |
Decitabine impurity 3 | 113476-23-6 | C21H22O6 | 370.41 |
Dimenhydrinate Impurity H HCl | C17H20BrNO.HCl | 334.26 36.46 | |
Dimenhydrinate Impurity K (Bis(diphenylmethy) Ether) | C26H22O | 350.46 | |
Dimenhydrinate Impurity D | C20H28N2O | 312.46 | |
Dimenhydrinate Impurity J | 119-61-9 | C13H10O | 182.22 |
Dimenhydrinate Impurity F | C16H19NO | 241.34 | |
Dimenhydrinate Impurity(8-chloro-1-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione) | 6136-36-3 | C6H5ClN4O2 | 200.59 |
Doxorubicinolone | C21H20O9 | 416.39 | |
Delphinidin 3-Sambubioside Chloride | C26H29O16 . Cl | 597.51 35.45 | |
Delphinidin 3-D-Glucoside | 6906-38-3 | C21H21O12 Cl | 465.39 35.45 |
Domoic acid | 14277-97-5 | C15H21NO6 | 311.34 |
Desmopressin Acetate | 62288-83-9 | C46H64N14O12S2 . C2H4O2 | 1069.24 60.05 |
Desmopressin-d5 | C46H59N14O12S2D5 | 1074.27 | |
Calcium Dobesilate | 20123-80-2 | (C6H5O5S)2. Ca | 418.41 |
Diphenidol HCl | 3254-89-5 | C21H27NO. HCl | 309.46 36.46 |
Enalaprilat(Enalapril EP Impurity C) | 76420-72-9 | C18H24N2O5 | 348.4 |
Enalapril EP Impurity H (Mixture of Isomers) | N/A | C20H34N2O5 | 382.5 |
Enalapril EP Impurity F Maleate | C22H32N2O5. C4H4O4 | 404.51 116.07 | |
Enalapril EP Impurity G (Mixture of Diastereomers) | C15H27NO4 | 285.39 | |
Enalapril-d5 | 349554-02-5 (non-d) | C20H23N2O5D5 | 381.49 |
Enalaprilat-d5 | 349554-00-3(non-d) | C18H19N2O5D5 | 353.43 |
Enalapril EP Impurity A (SSR) | 1356932-13-2 | C20H28N2O5 | 376.46 |
Enalapril Maleate | C20H28N2O5.C4H4O4 | 376.46 116.07 | |
Enalapril EP Impurity E Maleate | N/A | C26H32N2O5. C4H4O4 | 452.56 116.07 |
Enalapril EP Impurity D (Enalapril diketopiperazine) | 115729-52-7 | C20H26N2O4 | 358.44 |
Enalapril EP Impurity B | 82717-96-2 | 82717-96-2 | 279.34 |
Entacapone | 130929-57-6 | C14H15N3O5 | 305.29 |
Cis-Entacapone | 145195-63-7 | C14H15N3O5 | 305.29 |
Entacapone-d10 | 130929-57-6 (non-d) | C14H5N3O5D10 | 315.35 |
Entacapone Impurity G | 857629-78-8 | C15H17N3O5 | 319.32 |
Entacapone-3-beta-D-Glucuronide | 15869-75-1 | C20H23N3O11 | 481.42 |
N-Methyl Etodolac | NULL | C18H23NO3 | 301.39 |
(S)-Etodolac-d3 | C17H18NO3D3 | 290.38 | |
(R)-Etodolac-d3 | C17H18NO3D3 | 290.38 | |
8-Isopropyl Etodolac | 849630-65-5 | C18H23NO3 | 301.39 |
8-Propyl Etodolac | 57816-83-8 | C18H23NO3 | 301.39 |
1-Isopropyl Etodolac | 57917-63-2 | C18H23NO3 | 301.39 |
1-Propyl Etodolac | 57817-27-3 | C18H23NO3 | 301.39 |
Etodolac Impurity C | C16H19NO3 | 273.33 | |
6-Hydroxy Etodolac | NULL | C17H21NO4 | 303.36 |
Etodolac acyl glucuride | NULL | C23H29NO9 | 463.49 |
rac Etodolac | 41340-25-4 | C17H21NO3 | 287.36 |
(S)-Etodolac | C17H21NO3 | 287.36 | |
(R)-Etodolac | C17H21NO3 | 287.36 | |
Etodolac impurity A | C15H17NO3 | 259.31 | |
Etodolac impurity B | C16H19NO3 | 273.33 | |
rac Etodolac-13C-d3 | C17H18NO3D3 | 291.37 | |
Ezetimibe-d4 | 1093659-90-5 | C24H17F2NO3D4 | 413.46 |
4̢۪-O-Benzyl Ezetimibe | 163222-32-0 | C31H27F2NO3 | 499.56 |
ent-Ezetimibe | 1376614-99-1 | C24H21F2NO3 | 409.44 |
3-O-Acetyl ezetimibe | C26H23F2NO4 | 451.47 | |
Ezetimibe Diacetate | C28H25F2NO5 | 493.51 | |
Ezetimibe Tetrahydropyran Impurity (SCH59566) | 1296129-15-1 | C24H21F2NO3 | 409.44 |
Ezetimibe Impurity 1 ((3'S,3R,4S)-Desfluoro Ezetimibe) | 190595-66-5 | C24H22FNO3 | 391.45 |
Ezetimibe Azetidinone Ring-opened Impurity | 1391053-63-6 | C24H23F2NO4 | 427.45 |
Ezetimibe Phenexy Glucuronide | 190448-57-8 | C30H29F2NO9 | 585.56 |
Ezetimibe (3R,4R,3'R)-isomer | C24H21F2NO3 | 409.44 | |
Ezetimibe (3S,4S,3'S)-isomer | C24H21F2NO3 | 409.44 | |
Ezetimibe Fluoro Isomer | N/A | C24H21F2NO3 | 409.44 |
Ezetimibe (3S,4R,3'S)-Isomer | N/A | C24H21F2NO3 | 409.44 |
Ezetimibe Impurity ((S)-4-Phenyloxazolidin-2-one) | 99395-88-7 | C9H9NO2 | 163.18 |
Ezetimibe Deprotected Impurity ((S)-3-{(2R, 5S)-5-(4-Fluorophenyl)-2-[(S)-(4-Fluorophenylamino)-(4-OH-phenyl)methyl]-5-O | 1185883-04-2 | C33H30F2N2O5 | 572.61 |
Ezetimibe Impurity B | N/A | C12H15FO3 | 226.25 |
Ezetimibe Ring-Open Impurity | 1197811-72-5 | C24H23FNO3 | 411.45 |
Ezetimibe Dehydoxy Impurity | 204589-58-2 | C24H21F2NO2 | 393.44 |
Ezetimibe Hydroxy Glucuronide | 536709-33-8 | C30H29F2NO9 | 585.56 |
Ezetimibe Impurity 2 | C31H26FNO3 | 479.56 | |
Ezetimibe Impurity 3 | C31H26FNO3 | 479.56 | |
Ezetimibe Impurity 4 | C31H25F2NO3 | 497.55 | |
Ezetimibe Impurity 5 | C31H27F2NO3 | 499.56 | |
Benzyl Ezetimibe Diol (Mixture of Diastereomers) | C31H31F2NO3 | 503.59 | |
Ezetimibe Diol | 1374250-08-4 | C24H25F2NO3 | 413.47 |
Ezetimibe Lactam Cleaved Alcohol | C24H23F2NO2 | 395.45 | |
Ezetimibe (3R,4R,3'S)-Isomer | 1478664-02-6 | C24H21F2NO3 | 409.44 |
Ezetimibe (3S,4S,3'R)-Isomer | C24H21F2NO3 | 409.44 | |
Ezetimibe 2-Fluoro Impurity | C24H21F2NO3 | 409.44 | |
Ezetimibe | 163222-33-1 | C24H21F2NO3 | 409.44 |
Ezetimibe 3-Fluoro Impurity | C24H21F2NO3 | 409.44 | |
Ezetimibe Aniline Impurity | C24H22F2N2O2 | 408.45 | |
Ezetimibe desfluoro chloro impurity | C24H21ClFNO3 | 425.89 | |
Ezetimibe desfluoro methyl impurity | C25H24FNO3 | 405.47 | |
Ezetimibe ring-opening dehydrate impurity | 1292292-63-7 | C24H21F2NO3 | 409.44 |
Ezetimibe benzyl impurity | C31H27F2NO3 | 499.56 | |
Mixture of Ezetimibe (3R,4R,3'R)-Isomer and Ezetimibe (3R,4R,3'S)-Isomer | C24H21F2NO3 | 409.44 | |
Mixture of Ezetimibe (3S,4S,3'S)-Isomer and Ezetimibe (3S,4S,3'R)-Isomer | C24H21F2NO3 | 409.44 | |
Ezetimibe impurity (tetrahydro-pyran-2-one) | C24H21F2NO3 | 409.44 | |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(R)-hydroxy-pentanoyl]-4-(R)-phenyl-oxazolidin-2-one) | C20H20FNO4 | 357.39 | |
Ezetimibe-d4 phenolic glucuronide | NULL | C30H25F2NO9D4 | 589.59 |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(S)-phenyl-oxazolidin-2-one) | C20H20FNO4 | 357.39 | |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(R)-hydroxy-pentanoyl]-4-(S)-phenyl-oxazolidin-2-one) | C20H20FNO4 | 357.39 | |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(R)-phenyl-oxazolidin-2-one) | C20H20FNO4 | 357.39 | |
Ezetimibe Related Impurity 6 | N/A | C24H21F2NO3 | 409.44 |
Ezetimibe Related Impurity 7 | 204589-68-4 | C24H19F2NO2 | 391.42 |
Ezetimibe Impurity 8 | C20H18FNO4 | 355.37 | |
Ezetimibe Impurity 9 | 272778-12-8 | C39H46F2N2O5Si2 | 716.98 |
MBZT-2 | C31H27F2NO3 | 499.56 | |
(R)-Ezetimibe | 163380-16-3 | C24H21F2NO3 | 409.44 |
Ezetimibe Ketone | 191330-56-0 | C24H19F2NO3 | 407.42 |
Elvitegravir | C23H23ClFNO5 | 447.89 | |
Elvitegravir-d6 | N/A | C23H17ClFNO5D6 | 453.93 |
Elvitegravir-d8 | 697761-98-1 (non-labelled) | C23H15ClFNO5D8 | 455.94 |
Ezetimibe Impurity ((2R,3S)-2-[(4-Benzyloxyphenyl)-4-(4-Fluorophenylamino)methyl]pentanedioic acid) | 1013025-04-1 | C25H24FNO5 | 437.47 |
Enzalutamide | 915087-33-1 | C21H16F4N4O2S | 464.44 |
N-Desmethyl Enzalutamide-d6 | 1242137-16-1 (non-labelled) | C20H8F4N4O2SD6 | 456.45 |
N-Desmethyl Enzalutamide | 1242137-16-1 | C20H14F4N4O2S | 450.42 |
Enzalutamide-d3 | 1443331-82-5 | C21H13F4N4O2SD3 | 467.46 |
Desfluoro Ezetimibe | 302781-98-2 | C24H22FNO3 | 391.45 |
Ebastine Impurity E | C33H41NO2 . C4H4O4 | 483.70 116.07 | |
4-Demethyl Epipodophyllotoxin(DMEP) | 6559-91-7 | C21H20O8 | 400.39 |
Efavirenz-d5 | 154598-52-4 | C14H4ClF3NO2D | 320.71 |
Ertapenem-d4 Disodium | N/A | C22H19N3O7SD4 2Na | 477.53 2x22.99 |
Ertapenem Side Chain Enantiomer 1 | C20H19N3O7S | 445.45 | |
Ertapenem Side Chain Enantiomer 2 HCl | 503607-49-6 | C12H14N2O3S. HCl | 266.32 36.46 |
Ertapenem N-Carbonyl Dimer Impurity | 1199797-43-7 | C44H48N6O13S2 | 933.03 |
Ertapenem Dimer Ester Impurity | 402955-38-8 | C44H50N6O14S2 | 951.05 |
Ertapenem Impurity Pro-maba | C12H14N2O3 | 234.26 | |
Ertapenem Impurity DIPP | 220031-86-7 | C18H27N2O6PS | 430.46 |
Ertapenem side chain impurity (propyl ester) | C15H20N2O3S | 308.4 | |
Ertapenem Ring Open Impurity | C22H27N3O8S | 493.54 | |
Ertapenem Dimer Amide Impurity | C44H50N6O14S2 | 951.05 | |
rac Methyl Efavirenz | 353270-76-5 | C15H11ClF3NO2 | 329.71 |
Efavirenz impurity ((S)-6-chloro-4-{[(2RS,2RS)-2-methylcyclopropyl]ethynyl}-4-(trifluoromethyl)-2 H-3,1-benzoxazin-2-one | C15H11ClF3NO2 | 329.71 | |
Efavirenz impurity ((S)-6-chloro-4-(pent-1-ynyl)-4-(trifluoromethyl)-2 H-3,1-benzoxazin-2-one) | C14H11ClF3NO2 | 317.7 | |
Efavirenz impurity ((S)-6-chloro-4-(3-methylbut-3-en-1-ynyl)-4-(trifluoromethyl)-2 H-3,1-benzoxazin-2-one ) | C14H9ClF3NO2 | 315.68 | |
Efavirenz impurity ((S,Z)-6-chloro-4-(pent-3-en-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | C14H9ClF3NO2 | 315.68 | |
Efavirenz Benzoylaminoalcohol Impurity | C21H17ClF3NO3 | 423.82 | |
Efavirenz Cyclobutenylindole Impurity | C16H13ClF3NO2 | 343.74 | |
Efavirenz Penteneyne Impurity | C14H9ClF3NO2 | 315.68 | |
Efavirenz Cyclobutenylindole Impurity 2 | C16H13ClF3NO2 | 343.74 | |
Efavirenz | C14H9ClF3NO2 | 315.68 | |
Epoxiconazole-d4 | C17H9ClFN3OD4 | 333.79 | |
Epoxiconazole | 135319-73-2 | C17H13ClFN3O | 329.76 |
Efavirenz Related Compound A | 209414-27-7 | C13H11ClF3NO | 289.69 |
Esreboxetine Metabolite A | C19H23NO4 | 329.4 | |
Esreboxetine Metabolite B | C19H23NO4 | 329.4 | |
Esreboxetine Metabolite C | C17H19NO3 | 285.35 | |
3-Morpholine Metabolite | C19H21NO4 | 327.38 | |
Efavirenz Related Compound B | N/A | C14H11ClF3NO2 | 317.7 |
Emorfazone | 38957-41-4 | C11H17N3O3 | 329.28 |
Efavirenz Related Compound C | 391860-73-4 | C13H9ClF3N | 271.67 |
Diisopropyl Ether | 108-20-3 | C6H14O | 102.18 |
Efavirenz Ring-opening Impurity | N/A | C14H9ClF3NO2 | 315.68 |
Etomidate Impurity C HCl | 66512-39-8 | C15H18N2O2 HCl | 258.32 36.46 |
Efavirenz -R-isomer | C14H11ClF3NO2 | 317.7 | |
Emetine DiHCl | 316-42-7 | C29H40N2O4. 2 HCl | 480.65 2 36.46 |
8-Hydroxy Efavirenz | 205754-33-2 | C14H9ClF3NO3 | 331.68 |
rac 8-Hydroxy Efavirenz | 205754-32-1 | C14H9ClF3NO3 | 331.68 |
Aminobenzoylecgonine | C16H20N2O4 | 304.35 | |
Edoxaban Tosylate Hydrate | 1229194-11-9 | C24H30ClN7O4S. C7H8O3S. H2O | 548.07 172.20 18.02 |
Edoxaban-D6 | C24H24ClN7O4SD6 | 554.1 | |
Edoxaban impurity G | 1255529-26-0 | C24H30ClN7O4S | 548.07 |
Edoxaban impurity H | 1255529-28-2 | C24H30ClN7O4S | 548.07 |
Edoxaban impurity I | 1255529-23-7 | C24H30ClN7O4S | 548.07 |
Enoxacin | 74011-58-8 | C15H17FN4O3 | 320.33 |
Etiocholanolone | 53-42-9 | C19H30O2 | 290.45 |
11-beta-Hydroxy Etiocholanolone | 739-26-4 | C19H30O3 | 306.45 |
11-beta-Hydroxy Etiocholanolone-D5 | 739-26-4 (non-labelled) | C19H25O3D5 | 311.48 |
Enoxacin-d8 | 74011-58-8 (non-d) | C15H9D8FN4O3 | 328.35 |
Epichlorohydrin (1-Chloro-2, 3-Epoxypropane) | 106-89-8 | C3H5ClO | 92.53 |
Ethynodiol | N/A | C20H28O2 | 300.44 |
Ethynodiol-17-Acetate | N/A | C22H30O3 | 342.48 |
Ethynodiol Impurity (17-alfa-Ethinyl-17-beta-Acettoxy-3,5-Estradien Impurity) | 64850-62-0 | C22H28O2 | 324.47 |
Eperezolid | 165800-04-4 | C18H23FN4O5 | 394.41 |
Erdosteine | 84611-23-4 | C8H11NO4S2 | 249.31 |
Erdosteine thioacid diammonium salt | C8H13NO5S2. 2NH3 | 267.32 2x17.03 | |
Ethylcyclotene | 53263-58-4 | C8H12O2 | 140.18 |
Eluxadoline | 864821-90-9 | C32H35N5O5 | 569.67 |
Estradiol-d3 | 79073-37-9 | C18H21O2D3 | 275.41 |
2-Hydroxy Ethynyl Estradiol | C20H24O3 | 312.41 | |
3-Cypionate Estradiol | C26H36O3 | 396.58 | |
6-alpha Hydroxy Estradiol | C18H24O3 | 288.39 | |
Estradiol Valerate Impurity C | 95959-20-9 | C23H30O3 | 354.49 |
Ethinylestradiol Impurity G | C20H22O3 | 310.4 | |
17-alpha-Ethynyl Estradiol-3-Sulfate (Mixed with di-sulfate) | C20H24O5S | 376.48 | |
Ethynylestradiol Impurity E (6-alpha-Hydroxy Ethynylestradiol) | 27521-34-2 | C20H24O3 | 312.41 |
Ethynylestradiol Impurity F (6-beta-Hydroxy Ethynylestradiol) | 56324-28-8 | C20H24O3 | 312.41 |
6, 7-Didehydroethynylestradiol (Impurity I) | C20H22O2 | 294.4 | |
Estradiol-d3 Glucuronide | C24H29O8D3 | 451.54 | |
4-Methylestradiol Valerate | C24H34O3 | 370.54 | |
Delta-9(11)-Estradiol (Estradiol Hemihydrate Impurity D) | NA | C18H22O2 | 270.37 |
6-beta-Hydroxyestradiol | C18H24O3 | 288.39 | |
Estradiol 17-Butyrate | C22H30O3 | 342.48 | |
3,17-Divalerate Estradiol | C28H40O4 | 440.63 | |
3-Valerate Estradiol | C23H32O3 | 356.51 | |
Estradiol Valerate | 979-32-8 | C23H32O3 | 356.51 |
Ethinylestradiol Impurity H | C20H22O3 | 310.4 | |
Delta-9(11)-Estradiol 3-Enanthate | C25H34O3 | 382.55 | |
Estradiol Glucuronide | C24H32O8 | 448.52 | |
Delta-9(11)-Estradiol 17-Enanthate | C25H34O3 | 382.55 | |
17-epi Ethylnyl Estradiol (Impurity A) | 4717-38-8 | C20H24O2 | 296.41 |
9,11-Dehydro Ethylnyl Estradiol (Impurity B) | 1231-96-5 | C20H22O2 | 294.4 |
Ethynylestradiol Impurity M | 1818-11-7 | C21H24O2 | 308.42 |
17-epi Estradiol Valerate | C23H32O3 | 356.51 | |
17-epi-Estradiol (Estradiol Impurity B) | 57-91-0 | C18H24O2 | 272.39 |
17-Beta-Estradiol-3-O-Sulfate Sodium | 4999-79-5 | C18H23O5S Na | 351.45 22.99 |
Delta-8,9-Dehydro-Estradiol-3-O-Sulfate Sodium | 61612-83-7 | C18H19O5S Na | 347.41 22.99 |
17-alpha Estradiol-d3 | C18H21O2D3 | 275.41 | |
Diethinylestradienol | 79727-03-0 | C22H26O | 306.45 |
17-alpha-ethynylestradiol-d4 | NULL | C20H20O2D4 | 300.44 |
Estradiol 3-Enanthate | 55540-97-1 | C25H36O3 | 384.56 |
6-Ketoestradiol | 571-92-6 | C18H22O3 | 286.37 |
Ethinylestradiol Impurity K | 155683-61-7 | C21H26O2 | 310.44 |
1-Methyl Esthynyl Estradiol | 15071-66-6 | C21H26O2 | 310.44 |
Estradiol Impurity C (4-Methyl Estradiol) | 6171-48-8 | C19H26O2 | 286.42 |
4-Methyl Estradiol Enanthate Impurity | C26H38O3 | 398.59 | |
Estradiol related compound B | 7291-41-0 | C18H22O2 | 270.37 |
4-Methyl estradiol valerate | C24H34O3 | 370.54 | |
4-Hydroxy estradiol 1-N7-guanine | 178971-91-0 | C23H27N5O4 | 437.5 |
4-Hydroxy estradiol 1-N3-Adenine | 428506-88-1 | C23H27N5O3 | 421.5 |
Estradiol-d5 | C18H19O2D5 | 277.42 | |
Estradiol Benzoate Impurity E (17-epi- Estradiol Benzoate) | 6045-53-0 | C25H28O3 | 376.5 |
Erythrosine | 16423-68-0 | C20H6I4O5. 2 Na | 833.89 2 22.99 |
Estradiol | C18H24O2 | 272.39 | |
Estradiol Enanthate | 4956-37-0 | C25H36O3 | 384.56 |
Estradiol-d4 (17-beta-Estradiol-d4) | C18H20O2D4 | 276.41 | |
17-alpha Ethynyl Estradiol | C20H24O2 | 296.41 | |
Everolimus | NULL | C53H83NO14 | 958.25 |
Everolimus-d4 | 1338452-54-2 | C53H79NO14D4 | 962.27 |
Everolimus Related Compound 3 | C32H49NO9 | 591.75 | |
Everolimus Ring-Opening Impurity | C53H83NO14 | 958.25 | |
Everolimus Dehydrate Impurity | C53H83NO14 | 958.25 | |
Everolimus O-Desmethyl Impurity | C52H81NO14 | 944.22 | |
Everolimus O-Ethyl Impurity | C54H85NO14 | 972.28 | |
Everolimus 27-O-Desmethyl Impurity | C52H81NO14 | 944.22 | |
Everolimus 28-Ethylhydroxy Impurity | C53H83NO14 | 958.25 | |
Estrone-d4 | NULL | C18H18O2D4 | 274.4 |
Estrone Acetate | C20H24O3 | 312.41 | |
Delta-8,9-Dehydro Estrone | 474-87-3 | C18H20O2 | 268.26 |
Delta-8,9-Dehydro Estrone Sulfate Sodium Salt | 61612-83-7 | C18H19O5S Na | 347.41 22.99 |
4-Hydroxy estrone 1-N7-guanine | 178971-92-1 | C23H25N5O4 | 435.49 |
4-Hydroxy estrone 1-N3-Adenine | 488841-24-3 | C23H25N5O3 | 419.49 |
Estrone 3-Sulfate Sodium Salt | NULL | C18H21O5S.Na | 349.43 22.99 |
Estrone-d4 3-Sulfate Sodium Salt | 285979-80-8 | C18H17O5SD4.Na | 353.45 22.99 |
3-O-Methyl Estrone | C19H24O2 | 284.4 | |
Estrone-3-Glucuronide (Estrone beta-D-Glucuronide) | 2479-90-5 | C24H30O8 | 446.5 |
Estrone-d4-3-glucuronide (Estrone-d4 β-D-Glucuronide Sodium Salt) | C24H26O8D4 | 450.53 | |
4-Methoxy estrone | C19H24O3 | 300.4 | |
2-Methoxy estrone | C19H24O3 | 300.4 | |
Estrone | 53-16-7 | C18H22O2 | 270.37 |
Eletriptan | 143322-58-1 | C22H26N2O2S | 382.53 |
Eletriptan-d3 | 143322-58-1 (non-d) | C22H23N2O2SD3 | 385.55 |
Eletriptan N-oxide | C22H26N2O3S | 398.53 | |
N-Desmethyl eletriptan hydrochloride | C21H24N2O2S.HCl | 368.50 36.5 | |
Eplerenone Hydroxyacid Potassium salt | 95716-98-6 | C24H31O7.K | 431.51 39.10 |
Eplerenone-d3 | C24H27O6D3 | 417.52 | |
Eplerenone | 107724-20-9 | C24H30O6 | 414.49 |
Eplerenone-13C-d3 | 107724-20-9 (non-d) | C24H27O6D3 | 418.51 |
6β-Hydroxy Eplerenone | 209253-80-5 | C24H30O7 | 430.5 |
21-Hydroxy Eplerenone | C24H30O7 | 430.5 | |
Δ9,11-7β-Eplerenone | C24H30O5 | 398.5 | |
EDROPHONIUM | C10H11NOD5.Cl | 171.28 35.45 | |
Eprosartan Mesylate | 133040-01-4 | C23H24N2O4S.CH4O3S | 424.52 96.11 |
Eprosartan Impurity 1 | C26H30N2O4S | 466.6 | |
Eprosartan Impurity 2 | C19H20N2O6 | 372.38 | |
Eprosartan Impurity 3 | C18H20N2O4 . CH4O3S | 328.37 96.11 | |
Eprosartan Impurity 4 | C16H18N2O3 | 286.33 | |
Eprosartan-d4 | 133040-01-4 (non-d) | C23H20N2O4SD4 | 428.55 |
Eprosartan acyl glucuronide | C29H32N2O10S | 600.65 | |
Eprosartan related compound A | C15H18N2O2S | 290.39 | |
Eprosartan related compound B | 5928-51-8 | C7H8O2S | 156.2 |
Eprosartan related compound C | C8H8O4S | 200.21 | |
Eprosartan related compound D | 6232-88-8 | C8H7BrO2 | 215.05 |
Eprosartan related compound E | 3006-96-0 | C8H8O3 | 152.15 |
Eprosartan related compound F | 148674-39-9 | C23H24N2O4S | 424.52 |
Eicosapentaenoic acid (EPA) | 10417-94-4 | C20H30O2 | 302.46 |
Eicosapentaenoic acid (EPA) -d5 | 10417-94-4 (non-d) | C20H25O2D5 | 307.49 |
Eicosapentaenoic acid ethyl ester-d5 | C22H29O2D5 | 335.55 | |
Eicosapentaenoic acid ethyl ester | C22H34O2 | 330.52 | |
Ebastine | 90729-43-4 | C32H39NO2 | 469.67 |
Ebastine-d5 | 90729-43-4 (non-d) | C32H34NO2D5 | 474.7 |
Hydroxy Ebastine | C32H39NO3 | 485.67 | |
Hydroxy Ebastine-d5 | C32H34NO3D5 | 490.7 | |
Ebastine-d5 Fumarate | C32H34NO2D5.C4H4O4 | 474.70 116.07 | |
Ebastine Impurity B (4̢۪-tert-Butylacetophenone) | 943-27-1 | C12H16O | 176.26 |
Ebastine Impurity F | N/A | C32H39NO3 | 485.67 |
Ebastine Impurity G | N/A | C32H39NO3 | 485.67 |
Embonic Acid | C23H16O6 | 388.38 | |
Exemestane-d3 | C20H21O2D3 | 299.43 | |
Exemestane Related Compound B | 121021-51-0 | C20H26O3 | 314.43 |
Exemestane Related Compound | 881896-95-3 | C21H28O3 | 328.46 |
17β-Hydroxy Exemestane | C20H26O2 | 298.43 | |
17β-Hydroxy Exemestane Epoxide | C20H26O3 | 314.43 | |
Exemestane | C20H24O2 | 296.41 | |
Epoxy Exemestane | C20H24O3 | 312.41 | |
16α, 17α-Epoxy Exemestane | C20H24O2 | 296.41 | |
Exemestane Metabolite 1 | N/A | C20H27NO4S | 377.51 |
Exemestane Metabolite 2 | N/A | C21H28O4 | 344.45 |
Exemestane Related Compound A | 19457-55-7 | C20H26O2 | 298.43 |
Erythromycin-13C-D3 | C3H64NO1313CD3 | 737.95 | |
N-Desmethyl Erythromycin | C36H65NO13 | 719.92 | |
Erythromycin (Roxithromycin Impurity A) | 114-07-8 | C37H67NO13 | 733.95 |
Erythromycylamine | 26116-56-3 | C37H70N2O12 | 734.98 |
Erythromycylamine-13C-D3 | C37H67N2O12D3 | 738.98 | |
Etonogestrel-d6 (3-Keto-desogestrel-d6) | C22H22O2D6 | 330.5 | |
Etravirine | 269055-15-4 | C20H15BrN6O | 435.29 |
Etravirine-d6 | 269055-15-4 (non-d) | C20H9BrN6OD6 | 441.35 |
Etravirine-d4 | 269055-15-4 (non-d) | C20H11BrN6OD4 | 439.35 |
Dihydroxy Etravirine | 1246818-67-6 | C20H15BrN6O3 | 467.28 |
Monohydroxy Etravirine | 1246815-68-8 | C20H15BrN6O2 | 451.29 |
Entecavir | 142217-69-4 | C12H15N5O3 | 277.29 |
3',5'-Di-O-benzyl Entecavir | 142217-81-0 | C26H27N5O3 | 457.54 |
Entecavir Related Compound A (Impurity F) | 649761-24-0 | C27H31N5O2Si | 485.67 |
8-Hydroxy Entecavir | C12H15N5O4 | 293.28 | |
Entecavir Impurity A | N/A | C12H15N5O4 | 293.28 |
Entecavir Impurity E | N/A | C14H21N5O4Si | 351.44 |
Entecavir-d2 | 142217-69-4 (non-d) | C12H13N5O3D2 | 279.34 |
Entecavir-15N-13C2 | C1013C2H15N415NO3 | 280.26 | |
Entecavir Glucuronide | C18H23N5O9 | 453.41 | |
Entecavir Impurity ET-2 | C12H15N5O3 | 277.29 | |
(1R, 3S, 4S)-Entecavir (Impurity D) | N/A | C12H15N5O3 | 277.29 |
1̢۪-epi-Entecavir (Impurity B) | N/A | C12H15N5O3 | 277.29 |
(1R, 3R, 4R)- Entecavir | 1367369-76-3 | C12H15N5O3 | 277.29 |
3'-epi-Entecavir (Impurity C) | C12H15N5O3 | 277.29 | |
Eflornithine HCl | 96020-91-6 | C6H12F2N2O2 | 182.17 |
Eflornithine-15N-13C2 | C6H12F2N2O2 | 185.14 | |
Epinephrine (Adrenaline) | 51-43-4 | C9H13NO3 | 183.21 |
Adrenaline Impurity F | N/A | C9H13NO5S | 247.27 |
Normetanephrine HCl | 1011-74-1 | C9H13NO3. HCl | 183.21 36.46 |
D-(+)-Epinephrine | 150-05-0 | C9H13NO3 | 183.21 |
(±)-Metanephrine-d3 HCl (N-Methyl-d3) | 1215507-88-2 | C10H12NO3D3. HCl | 200.25 36.46 |
Adrenaline Impurity C | 62-13-5 | C9H11NO3 . HCl | 181.19 36.46 |
Deoxyepinephrine | 501-15-5 | C9H13NO2 | 167.21 |
Adrenaline Impurity | C10H15NO3 | 197.24 | |
Epinephrine-d3 | 51-43-4 (non-d) | C9H10NO3D3 | 186.23 |
Epinephrine Glucuronide | 54964-61-3 | C15H21NO9 | 359.34 |
Epinephrine-d6 | C9H7NO3D6 | 189.25 | |
Epinephrine Sulfate | 77469-50-2 | C9H13NO6S | 263.27 |
Metanephrine | 5001-33-2 | C10H15NO3 | 197.24 |
Epinephrine Sulfonic Acid | 26405-77-6 | C9H13NO5S | 247.27 |
Adrenaline Impurity D | N/A | C16H19NO3 | 273.33 |
Adrenaline Impurity E | N/A | C16H17NO3 | 271.32 |
Ethambutol-d4 Dihydrochloride | 1070-11-7 (non-labelled) | C10H20N2O2D4.2 HCl | 281.26 |
Ethambutol diHCl | 23981-47-7 | C10H24N2O2.2 HCl | 204.31 2 36.46 |
Ethambutol-d8 | C10H16N2O2D8 | 212.36 | |
Erlotinib HCl | 183319-69-9 | C22H23N3O4.HCl | 393.45 36.46 |
Erlotinib O-Desmethyl Metabolite Isomer (M14) HCl | 183320-51-6 | C21H21N3O4. HCl | 379.42 36.46 |
Erlotinib impurity, 6,7-bis(2-chloroethoxy) | 183321-82-6 | C20H17Cl2N3O2 | 402.28 |
Erlotinib impurity, 6-(2-methoxyethoxy)-7-(2-chloroethoxy) | 183321-83-7 | C21H20ClN3O3 | 397.86 |
Erlotinib impurity, 6-(2-chloroethoxy)-7-(2-methoxyethoxy) | 183321-85-9 | C21H20ClN3O3 | 397.86 |
Erlotinib impurity 1 | C22H24ClN3O4 | 429.91 | |
Erlotinib impurity 2 | C13H14Cl2N2O3 | 317.17 | |
Erlotinib impurity 3 | C14H16Cl2N2O4 | 347.2 | |
Erlotinib impurity 4 | C21H23N3O6 | 413.43 | |
Erlotinib Impurity (3-Ethynylailine) | 54060-30-9 | C8H7N | 117.15 |
Erlotinib-d6 HCl | C22H17N3O4D6.HCl | 399.48 36.46 | |
Erlotinib metabolite M11 | 882172-60-3 | C21H19N3O5 | 393.4 |
Desmethyl Erlotinib Carboxylate Acid | 1170354-84-3 | C21H19N3O5 | 393.4 |
Desmethyl Erlotinib | C21H21N3O4 | 379.42 | |
Erlotinib Hydroxy Metabolite | C22H23N3O5 | 409.45 | |
Erlotinib Carboxylic Acid | C22H25N3O6 | 427.46 | |
Erlotinib O-Desmethyl Metabolite Isomer (M13) | C21H21N3O4 | 379.42 | |
Didesmethyl Erlotinib | 183320-12-9 | C21H23N3O4 | 381.44 |
Ethacrynic Acid | 58-54-8 | C13H12Cl2O4 | 303.14 |
Ethacrynic Acid-d5 | 58-54-8 (non-labelled) | C13H7Cl2O4D5 | 308.17 |
Ethacrynic acid Impurity B | N/A | C13H13Cl3O4 | 339.61 |
Ethacrynic Acid Impurity A | N/A | C12H12Cl2O4 | 291.13 |
Ethacrynic Acid Impurity C | N/A | C26H24Cl4O8 | 606.29 |
17-Dihydroequilin | C18H22O2 | 270.37 | |
17-Dihydroequilin sulfate | C18H22O5S | 350.44 | |
Equilin-d4 Sulfate Sodium Salt | C18H15O5SD4.Na | 351.44 22.99 | |
Equilin-d4 | C18H16O2D4 | 272.38 | |
Equilin 3-Sulfate Sodium Salt | 16680-47-0 | C18H19O5S. Na | 347.41 22.99 |
Equilin | 474-86-2 | C18H20O2 | 268.36 |
Equilin 3-O-beta-D-Glucuronide Sodium Salt | 27610-12-4 | C24H27O8 . Na | 443.48 22.99 |
Equilin-d4 3-beta-O-D-Glucuronide Sodium Salt | C24H23O8D4 . Na | 447.50 22.99 | |
17-Dihydroequilenin | C18H20O2 | 268.36 | |
17-Dihydroequilenin sulfate | C18H20O5S | 348.42 | |
Equilenin Sulfate Sodium | 16680-48-1 | C18H17FO5S Na | 345.40 22.99 |
Equilenin | 517-09-9 | C18H18O2 | 266.34 |
17β-Dihydro Equilenin (BETA-EQUILENOL) | 1423-97-8 | C18H20O2 | 268.36 |
Erucamide | C22H43NO | 337.59 | |
Emedastine Difumarate | 87233-62-3 | C17H26N4O.C8H8O8 | 302.42 232.15 |
Emedastine-d5 | N/A | C17H21N4OD5 | 307.45 |
Emedastine-13C, d3 | N/A | C17H23N4OD3 | 306.43 |
Estriol | 50-27-1 | C18H24O3 | 288.39 |
Estriol Impurity A | 246021-20-5 | C18H22O3 | 286.37 |
Estriol Impurity C | 18650-87-8 | C19H26O3 | 302.42 |
Estriol Impurity E | 1228-72-4 | C18H24O3 | 288.39 |
Estriol Impurity F | 547-81-9 | C18H24O3 | 288.39 |
Estriol Impurity G | 793-89-5 | C18H24O3 | 288.39 |
17-alpha-Ethynylestriol | 4717-40-2 | C20H24O3 | 312.41 |
Eperisone Hydrochloride | 56839-43-1 | C17H25NO.HCl | 295.85 |
Eperisone-d10 Hydrochloride | C17H15NOD10.HCl | 305.92 | |
Omega-Hydroxy Eperisone (M3) | C17H25NO2 | 275.39 | |
Reduced Omega-Hydroxy Eperisone (M6) | C17H27NO2 | 277.41 | |
Omega-1-Hydroxy Eperisone (M4) | C17H25NO2 | 275.39 | |
Reduced Omega-1-Hydroxy Eperisone (M4) | C17H27NO2 | 277.41 | |
Ethionamide | 536-33-4 | C8H10N2S | 166.25 |
Ethionamide-d5 | C8H5N2SD5 | 171.28 | |
Ethionamide Sulfoxide | 536-28-7 | C8H10N2OS | 182.25 |
Ethionamide-d3 | C8H7N2SD3 | 169.26 | |
4-Thioisonicotinicamide | C6H6N2S | 138.19 | |
2-Methy-4-Thioisonicotinicamide | C7H8N2S | 152.22 | |
2,6-Diethyl-4-Thioisonicotinicamide | C10H14N2S | 194.3 | |
Etaqualone | C17H16N2O | 264.33 | |
Etifoxine | 21715-46-8 | C17H17ClN2O | 300.78 |
Etifoxine-d3 | C17H14ClN2OD3 | 303.81 | |
Etifoxine-d5 | C17H12ClN2OD5 | 305.82 | |
N-Desethyl Etifoxine | C15H13ClN2O | 272.74 | |
N-Desethyl Etifoxine-d3 | C15H10ClN2OD3 | 275.75 | |
N-Desethyl Etifoxine-d5 | C15H8ClN2OD5 | 277.77 | |
Etifoxine-13C-d3 | C1613CH14ClN2OD3 | 304.8 | |
N-Desethyl Etifoxine-13C-d3 | C1413CH10ClN2OD3 | 276.74 | |
Etifoxine Metabolite | C15H13ClN2O | 272.74 | |
Eprinomectin-d3 (Mixture of B1a and B1b) | 123997-26-2 (non-labelled) | C50H72NO14D3 (component B1a); C49H70NO14D3 (compon | 917.17 (component B1a); 903.14 (componen |
Eprinomectin | 123997-26-2 | 914.15; 900.13 | C50H75NO14; C49H73NO14 |
Emamectin-d3 (Mixture of B1a and B1b) | 119791-41-2 (non-labelled) | C49H72D3NO13 (B1a); C48H70NO13D3 (B1b) | 889.16 (B1a); 875.13 (B1b) |
Epinastine Hydrochloride | 108929-04-0 | C16H15N3.HCl | 285.78 |
7-Bromo Epinastine | 1217052-16-8 | C16H14BrN3 | 328.21 |
7-Chloro Epinastine Hydrochloride | 80012-45-9 | C16H14ClN3.HCl | 319.82 |
9-Oxo Epinastine HBr | 745761-19-7 | C16H13N3O. HBr | 263.30 80.91 |
Dehydro Epinastine Hydrochloride | 141342-70-3 | C16H13N3.HCl | 283.76 |
Epinastine Related Compound A | 41218-84-2 | C15H16N2 | 224.31 |
Epinastine Impurity A | C16H13N3 | 247.3 | |
Epinastine Impurity B HBr | 1217052-16-8 (free base) | C16H14BrN3. HBr | 328.21 80.91 |
Enrofloxacin | 93106-60-6 | C19H22FN3O3 | 359.4 |
Desfluroenrofloxacin Hydrochloride | 93107-11-0 | C19H24N3O3Cl | 377.87 |
Etoricoxib | 202409-33-4 | C18H15ClN2O2S | 358.85 |
Etoricoxib-d3 | C18H12ClN2O2SD3 | 361.87 | |
Etoricoxib-13C, d3 | N/A | C18H12ClN2O2SD3 | 362.86 |
Etoricoxib N-Oxide | 325855-74-1 | C18H15ClN2O3S | 374.85 |
Etoricoxib impurity 1 | 349536-39-6 | C18H13ClN2O4S | 388.83 |
Etoricoxib impurity 2 | 349536-41-0 | C18H15ClN2O3S | 374.85 |
Ethinylestradiol | 57-63-6 | C20H24O2 | 496.41 |
Ethinylesteradiol Impurity H (16-Oxo- Ethinylesteradiol) | 1350468-76-6 | C20H22O3 | 310.4 |
Ethinylesteradiol Impurity L | C18H24O2 | 272.39 | |
Ethinylestradiol-3-Glucuronide | 60134-76-1 | C26H32O8 | 472.53 |
(13S,14R, 17R)-Ethinylestradiol | C20H20O2 | 292.38 | |
(13S,14R, 17S)-Ethinylestradiol | C20H20O2 | 292.38 | |
(13S,14S, 17R)-Ethinylestradiol | C20H20O2 | 292.38 | |
(13S,14S, 17S)-Ethinylestradiol | C20H20O2 | 292.38 | |
Esmolol-d7 HCl | C16H18NO4D7.HCl | 302.42 36.46 | |
Esmolol-d7 Acid Sodium Salt | C15H15NO4D7. Na | 287.39 22.99 | |
Esmolol Acid Sodium Salt | C15H22NO4. Na | 280.35 22.99 | |
Esmolol HCl | 81161-17-3 | C16H25NO4.HCl | 295.38 36.46 |
Eltrombopag | 496775-61-2 | C25H22N4O4 | 442.48 |
Eltrombopag-13C4 | N/A | C25H22N4O4 | 446.43 |
Eltrombopag Olamine | 496775-62-3 | C25H22N4O4. 2 C2H7NO | 442.48 2 61.08 |
Eltrombopag Glucuronide | C31H30N4O10 | 618.61 | |
N-Acetyl -SB-611855 Glucuronide | C21H21NO10 | 447.4 | |
Eltrombopag Amide | C25H23N5O3 | 441.49 | |
Eltrombopag Ethyl Ester | C27H26N4O4 | 470.53 | |
Eltrombopag Methyl Ester | 1246929-01-0 | C26H24N4O4 | 456.51 |
2-Methoxy-3,5-dibromo aniline | C7H7Br2NO | 280.95 | |
2-Methoxy-3,6-dibromo aniline | C7H7Br2NO | 280.95 | |
2-Methoxy-3,4-dibromo aniline | C7H7Br2NO | 280.95 | |
Etafedrine HCl (Ethylephedrine HCl) | C12H19NO.HCl | 193.29 36.46 | |
Erythritol | 149-32-6 | C4H10O4 | 122.12 |
Erythritol -d3 | N/A | C4H7O4D3 | 125.14 |
9(Z)-Eicosenoic Acid (Gadoleic Acid) | 29204-02-2 | C20H38O2 | 310,52 |
9(Z)-Eicosenoic Acid Methyl Ester | 67810-35-9 | C21H40O2 | 324.55 |
Edaravone | 89-25-8 | C10H10N2O | 174.2 |
Edaravone Impurity III | 1357477-99-6 | C13H14N2O6S | 326.33 |
Edaravone Impurity IV | 7477-67-0 | C20H18N4O2 | 346.39 |
Edaravone Impurity V | C30H26N6O3 | 518.58 | |
Edaravone Impurity VI | 1323485-71-7 | C13H16N2O4S | 296.35 |
Econazole nitrate | C18H15Cl3N2O . HNO3 | 381.69 63.01 | |
Econazole nitrate impurity A | C11H10Cl2N2O | 257.12 | |
Econazole nitrate impurity B | C15H14Cl3NO | 330.64 | |
Econazole nitrate impurity C | C25H21Cl4N2O | 507.27 | |
2-Bromo-alpha-Ergocryptine-d3 | C32H37BrN5O5D3 | 657.63 | |
Esterastin | 67655-93-0 | C28H46N2O6 | 506.69 |
Esterastin-d3 | C28H43N2O6D3 | 509.71 | |
Emtricitabine Enantiomer | 137530-41-7 | C8H10FN3O3S | 247.25 |
Emtricitabine Ring-opening Impurity | N/A | C8H12FN3O4S | 265.26 |
Emtricitabine trans-Cyclic Impurity | C9H10FNO4S | 247.25 | |
Emtricitabine cis-Cyclic Impurity | C9H10FNO4S | 247.25 | |
Emtricitabine Dimer Impurity | C17H20F2N6O6S2 | 506.51 | |
Emtricitabine-d3 | N/A | C8H7FN3O3SD3 | 250.27 |
Emtricitabine Carboxylic Acid | 1238210-10-0 | C8H8FN3O4S | 261.23 |
Emtricitabine S-Oxide | 152128-77-3 | C8H10FN3O4S | 263.25 |
Emtricitabine | 143491-57-0 | C8H10FN3O3S | 247.25 |
Emtricitabine impurity B | C8H10FN3O3S | 247.25 | |
Emtricitabine impurity (2,3'-dideoxy-5-fluoro-3-thiouridine) | 145986-11-4 | C8H9FN2O4S | 248.23 |
5-epi-Emtricitabine | N/A | C8H10FN3O3S | 247.25 |
(2R, 5R)-Emtricitabine Acid | N/A | C8H8FN3O4S | 261.23 |
Etoposide-d3 | N/A | C29H29O13D3 | 591.59 |
Etoposide-13C, d3 | N/A | C29H29O13D3 | 592.58 |
Etoposide Hydroxy Acid | N/A | C29H34O14 | 606.59 |
Etoposide Impurity C | N/A | C29H32O13 | 588.57 |
Etoposide Impurity D | N/A | C27H30O13 | 562.53 |
Etoposide Impurity B | C29H32O13 | 588.57 | |
Epalrestat | 82159-09-9 | C15H13NO3S2 | 319.4 |
Epalrestat (Z, Z)-Isomer | N/A | C15H13NO3S2 | 319.4 |
Epalrestat (E, E)-Isomer | N/A | C15H13NO3S2 | 319.4 |
Epalrestat (E, Z)-Isomer | N/A | C15H13NO3S2 | 319.4 |
Epalrestat Dimer | C30H26N2O6S4 | 638.81 | |
Ergotamine | 113-15-5 | C33H35N5O5 | 581.68 |
8-Hydroxy Dihydro-Ergotamine (Mixture of Diastereomers) | N/A | C33H37N5O6 | 599.69 |
Dihydro Ergotamine-13C,d3 Mesylate | N/A | C33H34N5O5D3 CH4O3S | 587.70 96.11 |
Dihydro Ergotamine Mesylate | 6190-39-2 | C33H37N5O5 CH4O3S | 583.69 96.11 |
Dihydro Ergotamine Mesylate Related Compound 1 | C34H39N5O5 | 597.72 | |
Dihydro Ergotamine Mesylate Related Compound 2 | C33H37N5O6 | 599.69 | |
Dihydro Ergotamine Mesylate Related Compound 3 | C33H37N5O5 | 583.69 | |
Dihydro Ergotamine Mesylate Related Compound 4 | C35H41N5O5 | 611.75 | |
Esketamine Impurity C | 90717-17-2 | C12H13ClO2 | 224.69 |
Empagliflozin | 864070-44-0 | C23H27ClO7 | 450.92 |
Empagliflozin Sugar Dimer Impurity | C47H54Cl2O15 | 929.85 | |
Empagliflozin Sugar Dimer Impurity 1 | C46H52Cl2O14 | 899.82 | |
Empagliflozin Impurity 2 | C24H29ClO8 | 480.95 | |
(S)-Empagliflozin Peracetyl Impurity | C31H35ClO11 | 619.07 | |
Empagliflozin Impurity 3 | C23H27ClO7 | 450.92 | |
Empagliflozin Impurity 4 | C24H29ClO8 | 480.95 | |
Empagliflozin MonoAcetyl Impurity | C25H29ClO8 | 492.96 | |
Empagliflozin-d4 | N/A | C23H23ClO7D4 | 454.94 |
Empagliflozin Impurity A | C23H29ClO8 | 468.94 | |
Empagliflozin Impurity B | C23H27ClO7 | 450.92 | |
Empagliflozin Impurity C | C23H27ClO7 | 450.92 | |
Empagliflozin Impurity D | C23H28O7 | 416.48 | |
Empagliflozin Dimer Impurity | C34H32Cl2O4 | 575.54 | |
(S, R)-Empagliflozin Impurity | C23H27ClO7 | 450.92 | |
(S, S)-Empagliflozin Impurity | C23H27ClO7 | 450.92 | |
Eltenac | 72895-88-6 | C12H9Cl2NO2S | 302.8 |
Ethosuximide | 77-67-8 | C7H11NO2 | 141.17 |
Ethosuximide-d3 | 1189703-33-0 | C7H8NO2D3 | 144.19 |
Emodin | 518-82-1 | C15H10O5 | 270.24 |
Aloe Emodin | 481-72-1 | C15H10O5 | 270.24 |
Aloe Emodin Impurity A | 25395-11-3 | C21H16O8 | 396.36 |
Famciclovir-d4 | NULL | C4H15N5O4D5 | 325.36 |
Famciclovir dimer impurity 2 | C30H40N10O8 | 668.72 | |
Propionyl famciclovir | C15H21N5O4 | 335.37 | |
Famciclovir impurity 1 | 172529-94-1 | C10H14ClN5O2 | 271.71 |
Famciclovir impurity 2 | 23169-37-1 | C9H13N5O2 | 223.24 |
Famciclovir impurity 3 | 23169-37-1 | C11H17N5O3 | 267.29 |
Famciclovir impurity 4 | C10H11N5O5 | 281.23 | |
Famciclovir impurity 5 | 183475-21-0 | C11H15N5O3 | 265.27 |
Famciclovir impurity 6 | C20H28N10O5 | 488.51 | |
Famciclovir impurity 7 | 127205-22-5 | C10H15N5O3 | 253.26 |
Famciclovir 6-Alkylamino Impurity | N/A | C23H33N5O8 | 507.55 |
FAMCICLOVIR | C14H19N5O4 | 321.34 | |
Famciclovir N-Acetyl Impurity | N/A | C16H21N5O5 | 363.38 |
Famciclovir Deoxy-chloro Impurity | N/A | C12H16ClN5O2 | 297.75 |
8-Oxo-desacetylated famciclovir | C12H17N5O4 | 295.3 | |
Desacetyl Famciclovir | 104227-88-5 | C12H17N5O3 | 279.3 |
Famciclovir Chloro Impurity | N/A | C14H18ClN5O4 | 355.78 |
Famciclovir Dimer Impurity | N/A | C22H32N6O8 | 508.54 |
Famciclovir Related Compound A | 246021-75-0 | C10H15N5O2 . HCl | 237.26 36.46 |
Famciclovir Related Compound B | 104227-88-5 | C12H17N5O3 | 279.3 |
Famciclovir Related Compound C | 174155-70-5 | C12H17N5O2 | 263.3 |
Fenofibric acid | NULL | C17H15ClO4 | 318.76 |
Fenofibric acid-d6 | NULL | C17H9D6ClO4 | 324.8 |
Fenofibric Acyl Glucuronide | NULL | C23H23ClO10 | 494.89 |
Fenofibrate Impurity C | 217636-47-0 | C17H15ClO3 | 302.76 |
Fenofibrate Impurity F | 154356-96-4 | C16H15ClO2 | 274.75 |
Fenofibrate Impurity G | C24H27ClO6 | 446.93 | |
Fenofibrate impurity D | 42019-07-8 | C18H17ClO4 | 332.79 |
Fenofibrate impurity E | 42019-08-9 | C19H19ClO4 | 346.81 |
Fexofenadine HCl | 153439-40-8 | C32H39NO4.HCl | 538.13 |
Fexofenadine impurity L | C32H37NO3 | 483.66 | |
Fexofenadine-d10 HCl | 153439-40-8 | C32H29D10NO4.HCl | 548.19 |
Fexofenadine-d10 | 1215900-18-7 | C32H29NO4D10 | 511.73 |
Fexofenadine Methyl Ester | C33H41NO4 | 515.7 | |
Fexofenadine Related Compound A | C32H37NO4 | 499.66 | |
Fexofenadine Related Compound B | 479035-75-1 | C32H39NO4 | 501.67 |
Fexofenadine Decarboxylated Degradation Product | N/A | C31H39NO2 | 457.66 |
Fexofenadine Impurity G | C32H37NO3 | 483.66 | |
Fexofenadine impurity D | C32H35NO3 | 481.64 | |
Finasteride-d9 | NULL | C23H27N2O2D9 | 381.6 |
Finasteride Carboxylic Acid-D6 | C23H28N2O4D6 | 408.57 | |
Finasteride Triene Impurity | C23H32N2O2 | 368.52 | |
Finasteride Carboxylic Acid | 116285-37-1 | C23H34N2O4 | 402.54 |
Finasteride Impurity A | 98319-24-5 | C23H38N2O2 | 374.57 |
Finasteride Impurity B (Dutasteride Ester Impurity) | 103335-41-7 | C20H29NO3 | 331.46 |
Finasteride Impurity | 166896-74-8 | C23H36N2O2 | 372.56 |
Finasteride Impurity C | 1329611-51-9 | C23H34N2O2 | 370.54 |
Finasteride | 98319-26-7 | C23H36N2O2 | 372.56 |
Finasteride Related Compound C | C25H38N2O2 | 398.59 | |
Flumequine | 42835-25-6 | C14H12FNO3 | 261.26 |
Flumequine-13C3 | 42835-25-6(non-d) | C14H12FNO3 | 264.22 |
Levo-(-)-Flumequine | C14H12FNO3 | 261.26 | |
Dextro-(+)-Flumequine | C14H12FNO3 | 261.26 | |
Folinic Acid Calcium (Calcium Levofolinate) | 80433-71-2 | C20H21N7O7 . Ca | 471.43 40.08 |
Folinic Acid Impurity A (4-Aminobenzoyl Glutamic Acid) | 4271-30-1 | C12H14N2O5 | 266.26 |
Folinic Acid Impurity B | C21H23N7O8 | 501.46 | |
Folinic Acid Impurity C | C19H19N7O6 | 441.41 | |
Folinic Acid Impurity D | C20H19N7O7 | 469.42 | |
Folinic Acid Impurity E | 944737-05-7 | C15H16N6O4 | 344.33 |
Folinic Acid Impurity F | 28459-40-7 | C20H21N7O7 | 471.43 |
Folinic Acid Impurity G (7,8-Dihydrofolic Acid) | 4033-27-6 | C19H21N7O6 | 443.42 |
Folinic Acid Impurity H | C20H23N7O7 | 473.45 | |
Furazolidone | 67-45-8 | C8H7N3O5 | 225.16 |
Flumazenil Impurity D | 78755-80-3 | C10H9FN2O2 | 208.19 |
Flumazenil Impurity E | C15H15N3O3 | 285.31 | |
Flumazenil Related Compound A | C13H10FN3O3 | 275.24 | |
Flumazenil Related Compound B | C15H15N3O4 | 301.3 | |
Flumazenil Related Compound C | 1188-33-6 | C7H17NO2 | 147.22 |
Fluoxetine HCl | 59333-67-4 | C17H18H3NO.HCl | 345.79 |
Fluocortolone Pivalate | 29205-06-9 | C27H37FO5 | 460.59 |
Fluocortolone | 152-97-6 | C22H29FO4 | 376.47 |
Clocortolone caproate | 4891-71-8 | C28H38ClFO5 | 509.06 |
Difluocortolone Valerate | 59198-70-8 | C27H36F2O5 | 478.58 |
Clocortolone Pivalate | 34097-16-0 | C27H36ClFO5 | 495.04 |
Clocortolone | 4828-27-7 | C22H28ClFO4 | 410.92 |
Fluoxetine-d5 HCl | 59333-67-4 | C17H13F3N0D5.HCl | 314.36 36.46 |
Fipronil | 120068-37-3 | C12H4Cl2F6N4OS | 437.15 |
Fipronil Desulfinyl | 205650-65-3 | C12H4Cl2F6N4 | 389.09 |
Fipronil Sulfide | 120067-83-6 | C12H4Cl2F6N4S | 421.15 |
Fipronil Sulfone | 120068-36-2 | C12H4Cl2F6N4O2S | 453.15 |
Norfluoxetine HCl | NULL | C16H16F3NO.HCl | 331.77 |
Farnesane | 3891-98-3 | C15H32 | 212.42 |
Norfluoxetine-d5 HCl | NULL | C16H11D5F3NO.HCl | 336.8 |
Filgrastim | C845H1343N223O243S9 | 18802.8 | |
Fluoxetine Impurity A | N/A | C10H15NO | 165.24 |
Fenretinide | 65646-68-6 | C26H33NO2 | 391.56 |
Fenretinide-d4 | 65646-68-6 (non-labelled) | C26H29NO2D4 | 395.58 |
3-Keto Fenretinide | 865536-65-8 | C26H31NO3 | 405.54 |
3-Keto Fenretinide-d4 | C26H27NO3D4 | 409.57 | |
Fenretinide Glucuronide | 79982-82-4 | C32H41NO8 | 567.69 |
13-cis-Fenretinide | C26H33NO2 | 391.56 | |
4-Methoxy Fenretinide | C27H35NO2 | 405.59 | |
4-Methoxy Fenretinide-d4 | C27H31NO2D4 | 409.61 | |
Fenretinide-d4 Glucuronide | 79982-82-4 (non-labelled) | C32H37NO8D4 | 571.71 |
Fluoxetine Impurity B | N/A | C10H15N | 149.24 |
Fidaxomicin | 873857-62-6 | C52H74Cl2O18 | 1058.06 |
Mono-Methylated Fidaxomicin | C53H76Cl2O18 | 1072.09 | |
Di-Methylated Fidaxomicin | 185248-68-4 | C54H78Cl2O18 | 1086.12 |
Fidaxomicin-d7 | N/A | C52H67Cl2O18D7 | 1065.11 |
Fluoxetine Impurity C (Fluoxetine USP Related Compound A) | 79088-29-2 | C17H18F3NO | 309.33 |
Fluroxypyr-13C2 | 69377-81-9 (non-labelled) | C7H5Cl2FN2O3 | 257.01 |
Fluoxetine USP Related Compound C | N/A | C21H22F3NO4 | 409.41 |
AB-FUBINACA | 1185282-01-2 | C20H21FN4O2 | 368.41 |
4' -Hydroxy flurbiprofen | NULL | C15H13FO3 | 260.27 |
Flurbiprofen Impurity C | C15H13FO3 | 260.27 | |
Firocoxib | 189954-96-9 | C17H20O5S | 336.41 |
Flurbiprofen Impurity D | C14H11FO | 214.24 | |
Flurbiprofen Impurity E | C13H9FO2 | 216.21 | |
Flurbiprofen Axetil (Mixture of Diastereomers) | 91503-79-6 | C19H19FO4 | 330.36 |
(S)-Flurbiprofen | 51543-39-6 | C15H13FO2 | 244.27 |
(R)-Flurbiprofen | C15H13FO2 | 244.27 | |
Desfluoro flurbiprofen axetil | C19H20O4 | 312.37 | |
Flurbiprofen Related Impurity 1 | 42771-81-3 | C20H21FO4 | 344.39 |
Flurbiprofen Related Impurity 2 | 42771-82-4 | C16H13FO4 | 288.28 |
(R)-Flurbiprofen Axetil | N/A | C19H19FO4 | 330.36 |
Flurbiprofen Acyl Glucuronide (racemic mixture) | C21H21FO8 | 420.4 | |
(S)-Flurbiprofen Axetil (Mixture of Diastereomers) | 1401087-64-6 | C19H19FO4 | 330.36 |
6-Hydroxy Fludrocortisol | C21H29FO6 | 396.46 | |
Methyl Flurbiprofen | 66202-86-6 | C16H15FO2 | 258.3 |
Flurbiprofen-13C-D3 | C14H10FO213C D3 | 248.28 | |
Floxuridine | 50-91-9 | C9H11FN2O5 | 246.2 |
5'-(3-MAL-PEG2-aminobutanoate)-floxuridine | C29H42FN5O13 | 687.68 | |
Flurbiprofen-d3 | C15H10FO2D3 | 247.29 | |
Flunarizine DiHCl | 30484-77-6 | C26H26F2N2. 2 HCl | 404.51 2 36.46 |
Flunarizine Impurity B | C26H27FN2 | 386.52 | |
Flunarizine Impurity C | C26H26F2N2 | 404.51 | |
Flunarizine Impurity D | C26H26F2N2 | 404.51 | |
S-Flurbiprofen-acyl-β-D-glucuronide | C21H21FO8 | 420.4 | |
Gnaphaline A (5,7-Dihydroxy-3,8-Dimethoxyflavone) | 33803-42-8 | C17H14O6 | 314.3 |
R-Flurbiprofen-acyl-β-D-glucuronide | C21H21FO8 | 420.4 | |
Fenpiverinium Bromide | 125-60-0 | C22H29N2O Br | 337.49 79.90 |
Flurbiprofen | 5104-49-4 | C15H13FO2 | 244.27 |
Faropenem Impurity | 195716-77-9 | C12H14NO5S.Na | 284.31 22.99 |
Faropenem Related Compound 1 | 106560-32-1 | C16H29NO4SSi | 359.56 |
Faropenem Related Compound 2 | 429691-43-0 | C21H33NO7SSi | 471.65 |
Faropenem Related Compound 3 | 120705-67-1 | C21H33NO5SSi | 439.65 |
Faropenem Related Compound 4 | 106559-80-2 | C15H19NO5S | 325.39 |
4-AA ((2R,3R)-3-((R)-1-(tert-Butyldimethylsilyloxy)ethyl)-4-oxoazetidin-2-yl acetate) | 76855-69-1 | C13H25NO4Si | 287.43 |
(R)-Tetrahydrofuran-2-carbothioic S-acid | 153165-72-1 | C5H8O2S | 132.18 |
Flurbiprofen Related Compound A (Biprofen) | 6341-72-6 | C15H14O2 | 226.28 |
Faldaprevir | 801283-95-4 | C40H49BrN6O9S | 869.84 |
Faldaprevir-D3 | C40H46BrN6O9SD3 | 872.86 | |
Flurbiprofen Impurity B | C18H17FO4 | 316.33 | |
2-Fluoro-9-fluorenone-9-13C | C13H7FO | 199.19 | |
Furosine DiHCl | 19746-33-9 | C12H18N2O4 . 2 HCl | 254.29 2 36.46 |
Fluticasone propionate | 80474-14-2 | C25H31F3O5S | 500.58 |
Fluticasone Impurity F | 1219174-94-3 | C25H29F3O5S | 498.57 |
Fluticasone Impurity H | NA | C48H58F4O10S2 | 935.11 |
Fluticasone Impurity I | NA | C48H58F4O10S3 | 967.18 |
Fluticasone Dimer Impurity (Impurity G) | 220589-37-7 | C43H51F5O8S | 822.94 |
Fluticasone Impurity | C26H33F3O5S | 514.61 | |
Fluticasone Related Compound B | 219719-95-6 | C22H24F2O5S | 438.49 |
Fluticasone-d3 17 beta-Carboxylic Acid | C21H23F2O5D3 | 399.45 | |
Fluticasone Impurity (Cyclic thioester ) | C24H28F2O5S | 466.55 | |
Fluticasone propionate-d5 | 1093258-28-6 | C25H26D5F3O5S | 505.61 |
Fluticasone Impurity (17-Keto) | C20H24F2O3 | 350.41 | |
Fluticasone Impurity (17-alpha Propionate ) | C25H31F3O5S | 500.58 | |
Fluticasone Impurity (5-Iodo Methyl Propionate ) | C25H31F2IO5S | 608.49 | |
Fluticasone Impurity (6-Defluro-6-Oxo Propionate ) | C25H30F2O6S | 496.58 | |
Fluticasone furoate | 397864-44-7 | C27H29F3O6S | 538.59 |
Fluticasone furoate-d3 | 397864-44-7 (non-labelled) | C27H26D3F3O6S | 541.61 |
Fluticasone Impurity A | NA | C24H30F2O6 | 452.5 |
Fluticasone Impurity B | 948566-12-9 | C24H30F2O6S | 484.56 |
Fluticasone Impurity C | NA | C24H29F3O5S | 486.55 |
Fluticasone Impurity D | 73205-13-7 | C25H32F2O5S | 482.59 |
Fluticasone Impurity E | 105613-90-9 | C25H33F3O5S | 502.6 |
Flufenamic Acid | 530-78-9 | C14H10F3NO2 | 281.24 |
Fluvastatin sodium salt | 93957-55-2 | C24H25FNO4.Na | 433.46 |
Fluvastatin Degradation Product (diastereomeric mixture) | C24H26FNO4 | 411.48 | |
(R)-(-)-Falcarinol | 21852-80-2 | C17H24O | 244.38 |
(+)-3R,5S-Fluvastatin-d6 sodium salt | 155229-75-7 (non-d) | C24H19FNO4D6.Na | 416.51 22.99 |
(-)-3S,5R-Fluvastatin-d6 sodium salt | 155229-76-8 (non-d) | C24H19FNO4D6.Na | 416.51 22.99 |
Fluvastatin Ketone Sodium Salt | C24H25FNO4.Na | 410.47 22.99 | |
Fluvastatin Methyl Ester | 786710-21-2 | C25H28FNO4 | 425.5 |
Fluvastatin t-Butyl Ester | 194934-96-8 | C28H34FNO4 | 467.59 |
Fluvastatin Hydroxy Diene Impurity | C24H23FNO3.Na | 392.45 22.99 | |
Fluvastatin-d6 sodium salt | 93957-55-2(non-d) | C24H19D6FNO4.Na | 439.5 |
Fenoprop ( 2-(2,4,5-Trichlorophenoxy)propionic acid) | 93-72-1 | C9H7Cl3O3 | 269.51 |
Fenoprop-D3 ( 2-(2,4,5-Trichlorophenoxy)propionic acid-D3) | C9H4Cl3O3D3 | 272.53 | |
(+)-3R,5S-Fluvastatin sodium salt | 155229-75-7 | C24H25FNO4.Na | 439.5 |
(-)-3S,5R-Fluvastatin sodium salt | 155229-76-8 | C24H25FNO4.Na | 439.5 |
(3R,5R)-Fluvastatin Sodium Salt | NULL | C24H25FNO4.Na | 410.47 22.99 |
(3S,5S)-Fluvastatin Sodium Salt | 194935-01-8 | C24H25FNO4.Na | 410.47 22.99 |
Fluvastatin Sodium Salt-mixture of four isomers | NULL | C24H25FNO4.Na | 410.47 22.99 |
Fluvastatin lactone (racemic mixture) | NULL | C24H24FNO3 | 393.46 |
Fluvastatin lactone-mixture of four isomers | NULL | C24H24FNO3 | 393.46 |
(R,R)-Formoterol-d3 | 1198353-13-7 | C19H21N2O4D3 | 347.43 |
Formoterol Impurity B | 1224588-66-2 | C18H22N2O4 | 330.39 |
Formoterol Impurity C | C20H26N2O4 | 358.44 | |
Formoterol Impurity D (Mixture of Diastereomers) | C20H26N2O4 | 358.44 | |
Formoterol Impurity E (Mixture of Diastereomers) | 1616967-26-0 | C20H26N2O4 | 358.44 |
Formoterol Impurity F (Mixture of Diastereomers) | C37H46N4O6 | 642.8 | |
Formoterol Impurity H | C26H30N2O4 | 434.54 | |
(R, S)-Formoterol | C19H24N2O4 | 344.41 | |
Formoterol-D7 | C19H17N2O4D7 | 351.46 | |
Formoterol-13C, d3 | 73573-87-2(non-d) | C19H21D3N2O4 | 348.47 |
Formoterol Hemifumarate | C19H24N2O4 . 0.5 C4H4O4 | 344.41 0.5 116.07 | |
Formoterol Impurity G HCl | 3706-26-1 | C10H15NO.HCl | 165.24 36.46 |
Formoterol Impurity A (Mixture of Diastereomers) | 150513-24-9 | C18H24N2O3 | 316.4 |
Formoterol Benzylic Glucuronide (mixture of diastereomers) | C25H32N2O10 | 520.54 | |
Formoterol Phenolic Glucuronide | C25H32N2O10 | 520.54 | |
Formoterol Sulfate | C19H24N2O7S | 424.48 | |
(S, S)-Formoterol | 67346-48-9 | C19H24N2O4 | 344.41 |
Fosinopril sodium salt | 88889-14-9 | C30H45NO7P.Na | 585.66 |
Fosinopril Impurity H | 149760-14-5 | C16H25NO4 | 295.38 |
Fosinopril Related Compound C | C30H45NO7P . Na | 562.67 22.99 | |
Fosinopril impurity F | C29H44NO7P | 549.65 | |
Fosinopril Related Compound B | C30H46NO7P | 563.68 | |
Fosinopril impurity (2R, 4S isomer) | C30H46NO7P | 563.68 | |
Fosinopril-d7 sodium salt | 88889-14-9 (non-d) | C30H38D7NO7P.Na | 592.7 |
Fosinoprilat (Fosinopril Impurity B) | 95399-71-6 | C23H34NO5P | 435.5 |
Fosinoprilat-d7 | 95399-71-6 (non-d) | C23H27D7NO5P | 442.55 |
Fosinopril Impurity A | 83623-61-4 | C12H17O4P | 256.24 |
Fosinopril Impurity C | 90657-55-9 | C11H19NO2.HCl | 197.28 36.46 |
Fosinopril Impurity D | 128948-00-5 | C19H29O6P | 384.41 |
Fosinopril Impurity G | 46348-61-2 | C10H15O3P | 214.2 |
Dehydro Felodipine | 96382-71-7 | C18H17Cl2NO4 | 382.25 |
Felodipine | 72509-76-3 | C18H19Cl2NO4 | 384.26 |
Felodipine-d5 | 72509-76-3 (non-d) | C18H14Cl2NO4D5 | 389.29 |
Dehydro Felodipine-d5 | C18H12Cl2NO4D5 | 387.28 | |
Felodipine-13C4-d3 | 72509-76-3 (non-d) | C18H16Cl2NO4D3 | 391.24 |
Felodipine metabolite | C17H15Cl2NO5 | 384.22 | |
Felodipine Metabolite Lactone | C17H13Cl2NO4 | 366.2 | |
Felodipine Impurity B | 91189-59-2 | C17H17Cl2NO4 | 370.24 |
Felodipine Impurity C | 79925-38-5 | C19H21Cl2NO4 | 398.29 |
Fluconazole-d4 | 86386-73-4 (non-d) | C13H8F2N6OD4 | 310.3 |
Fluconazole Impurity D | 81886-51-3 | C13H13FN6O | 288.29 |
Fluconazole Impurity G | C12H11F2N3O4S | 331.3 | |
Fluconazole Impurity H | C11H10BrF2N3O | 318.12 | |
Fluconazole Impurity F | C10H9F2N3O | 225.2 | |
Fluconazole Impurity E | C10H9F2N3O | 225.2 | |
Fluconazole Impurity I | C13H14F2N7O | 322.3 | |
Fluconazole N-Oxide | N/A | C13H12F2N6O2 | 322.28 |
Fosfluconazole | 194798-83-9 | C13H13F2N6O4P | 386.26 |
Fluconazole Impurity (1-(2,4-Difluorophenyl)-1-(1H-1,2,4-Triazol-1-yl)-2,3-Epoxy Propane Methanesulfonate Salt) | 86386-77-8 | C11H9F2N3O CH4O3S | 237.21 96.11 |
Fosfluconazole Phosphate Impurity 1 | N/A | C13H13F2N6O4P | 386.26 |
Fluconazole | C13H12F2N6O | 306.28 | |
Fosfluconazole Phosphate Impurity 2 | N/A | C13H14FN6O4P | 368.27 |
Fluconazole Related Compound (2,4-Difluoro-alpha-(1H-1,2,4-triazolyl)acetophenone) | 86404-63-9 | C10H7F2N3O | 223.18 |
Fluconazole Impurity A | N/A | C13H12F2N6O | 306.28 |
Fluconazole Impurity B | N/A | C15H14FN9O | 355.34 |
Fluconazole Impurity C | 514222-44-7 | C10H8N6 | 212.22 |
Fluconazole Beta-D-Glucuronide | N/A | C20H22F2N6O6 | 480.43 |
Fluconazole Impurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] | N/A | C7H8N6O | 192.18 |
Fosamprenavir | 226700-79-4 | C25H36N3O9PS | 585.62 |
Fosamprenavir-d9 | 226700-79-4 (non-d) | C25H27N3O9PSD9 | 594.67 |
Fosamprenavir-d4 Calcium salt | 226700-79-4 (non-d) | C25H30N3O9PSD4.Ca | 587.63 40.08 |
Fosamprenavir Related Compound | C20H30N3O6PS | 471.52 | |
Fosamprenavir enantiomer | C25H36N3O9PS | 585.62 | |
Formestane | 566-48-3 | C19H26O3 | 302.42 |
R-Frovatriptan | 158747-02-5 | C14H19N3O | 243.33 |
S-Frovatriptan | C14H19N3O | 243.33 | |
Frovatriptan-d3 | C14H16N3OD3 | 246.35 | |
Frovatriptan Racemate | C14H17N3O | 243.31 | |
Frovatriptan Succinate | 158930-17-7 | C18H23N3O5 | 361.4 |
Methyl (7,7-Dimethyl-1,3-Oxobicyclo[2,2,1]hept-1-yl)methane Sulfonate | N/A | C11H18O4S | 246.33 |
Isopropyl (7,7-Dimethyl-1,3-Oxobicyclo[2,2,1]hept-1-yl)methane Sulfonate | N/A | C13H22O4S | 274.38 |
Fluvoxamine acid | C14H17F3N2O3 | 318.3 | |
Fluvoxamine Impurity E | 1217214-94-2 | C15H22F2N2O2 | 300.35 |
Fluvoxamine Oxime Impurity | 88699-84-7 | C13H16F3NO2 | 275.27 |
Fluvoxamine Impurity G | 192876-02-1 | C14H19F3N2O2 | 304.31 |
Fluvoxamine Maleic Acid Monoamide Impurity | N/A | C19H23F3N2O5 | 416.4 |
Fluvoxamine Impurity F | 1217262-11-7 | C17H26F3N3O2 | 361.41 |
Fluvoxamine-d3 | 54739-18-3 (non-d) | C15H18F3N2O2D3 | 321.36 |
Fluvoxamine-d4 | 54739-18-3 (non-d) | C15H17F3N2O2D4 | 322.37 |
Cis-Fluvoxamine | C15H21F3N2O | 318.34 | |
Trans-Fluvoxamine | 39-18-3 | C15H21F3N2O2 | 318.34 |
Fluvoxamine Maleate | C15H21F3N2O2.C4H4O4 | 318.34 116.07 | |
Fluvoxamine Impurity (5-Methoxy-4-Trifluoromethyl Valerophenone) | C13H15F3O2 | 260.26 | |
Valerophenone | 1009-14-9 | C11H14O | 162.23 |
Fluvoxamine Impurity C | C19H25F3N2O6 | 434.42 |
Comments
Post a Comment